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ABSTBACT 
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and International Perspectives. (April 2003) 
Melissa June Henry 
Department of Journalism 
Texas AkM University 
Fellows Advisor: Dr. Barbara Gastel 
Department of Journalism 
Ethical issues in scientific communication 
have existed in the scientific community 
since 
before the 17u century publication of the 
first scientific journal. 
To understand the historical development 
of scientific publication ethics as its 
own tield 
of research, I did a comprehensive review 
of lntemct sites and books and articles 
published after 
1970. To help fill in gaps in the literature, 
I sent an electronic survey to 26 
researchers with 
experience as editors, authors, and peer 
reviewers. 
I found that five main topics in 
publication ethics have received the 
largest amount of 
attention over the last 25 years: peer 
review, authorship, confiict of interest, 
publication bias, and 
duplicate/redundant publication. 
Since the 1970s, when research reports 
and other articles on these topics 
were first 
published with regularity, the number 
of studies published annually has 
increased substantially. 
Conferences, such as the International 
Peer Review Congresses, have 
focused on ethical issues, 
and many scientific organizations 
have created guidelines for ethical 
practices in scientific 
publishing. 
Different nations and fields have 
different codes and guidelines regarding 
ethical issues 
in scientific publishing. In national 
guidelines, it appears that there is an 
inverse relationship 
between guideline stringency and the 
amount of political freedom allowed 
under that nation's 
government. 
iv 
Of the 26 surveys sent, 13 were returned. Of those 
surveyed, most. stated that they were 
only somewhat aware of guidelines, and responses 
indicated that few researchers surveyed were 
aware of many instances of misconduct. 
Debate over each issue has increased, but no 
commonly accepted ethical practices have 
been developed. Awareness of these issues does 
not appear to have increased nor does it appear 
that the rate of occurrence of ethical infractions has 
decreased. This apparent unchanging rate of 
occurrence may be because, as publication has 
increased in most fields, scientists lack time to 
read articles outside of their own areas of research. A 
more comprehensive survey, distributed 
on a much larger scale, would be useful to 
better understand the causes of continued ethical 
infractions and to help develop practical 
solutions to ethical problems. 
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CHAPTER I 
INTRODUCTION 
Scientific publication is not only vital to the 
dissemination of knowledge and the growth 
of the scientific community, but also teeming with 
ethical issues and dilemmas. These issues 
and dilemmas are otten unavoidable and 
inherent to the process of scientific publication. For 
example, credit for new discoveries is often 
assigned based on authorship; thus, issues 
related to 
authorship are inevitable. By studying ethical 
issues, it is possible to develop some solutions 
to 
the dilemmas these issues create. These 
solutions help to preserve public trust in 
scientists and 
trust among scholars. Both forms of trust are 
essential. Public trust allows the implementation 
of new knowledge and discoveries; trust among scholars 
allows teamwork to occur and scholars 
to build upon the work of others without having 
to reinvent the wheel. 
Although many studies of ethics in scientific 
publication have already been conducted, 
these studies mainly examine single issues 
or groups of issues. For example, Lock's book 
A 
Difficult Balance: Editorial Peer Review in 
Medicine' describes the process ol editorial peer 
review and covers nearly all the ethical 
issues regarding peer review that had developed 
at the 
time it was published. There appear to be 
few works that consider multiple ethical 
issues in 
scientific publication. One exception is Ethics 
and Policy in Scientific Publication, published 
in 
1990 by the Council of Biology Editors. 
While this book examines many issues, it 
does not look 
at them in a historical context nor does it 
deal with the development of these issues. lt also 
appears that previous works have not 
drawn comparisons between accepted ethical 
practices 
among nations. 
Understanding the main groups of issues in scientific 
publication ethics and their 
historical development is critical. Seeing the 
progress that has been made to date will help 
determine how effective published articles and 
guidelines have been in educating scientists 
and 
increasing the awareness of ethical issues in the 
scientific community. This may provide insight 
into how issues will further develop in 
the future and may suggest ways to encourage 
ethical 
conduct in scientilic publication. 
This thesis follows the style and format of 
Science Editor. 
Examining differences among nations and 
fields is a crucial step in the analysis of these 
issues. By comparing the practices 
considered acceptable or appropriate in 
different nations and 
scientific fields, differences can be acknowledged 
and perhaps solutions to some ethical 
problems in scientific publishing can be 
generated. 
To gain an understanding of the main groups 
of issues in scientific publishing, I 
conducted a comprehensive review of Internet 
sites and books and articles published 
after 1970. 
I also sent an electronic survey to 26 
researchers with experience as editors, authors, 
and peer 
reviewers. My methods are detailed in 
Chapter II. 
Basically, the main issues in scientific 
publication ethics fall into five groups: peer 
review, authorship, conflict of interest, 
publication bias, and duplicate/redundant 
publication. 
These groups of issues are explained and 
examined in Chapter 111. 
Chapter IV is a brief account of the history 
of ethical issues in scientific publication and 
their development. The origins of the 
scientific journal, calls for research and reform, the 
literature, the International Peer Review 
Congresses, and ethical codes and guidelines 
are 
examined in this chapter in historical 
perspective. 
In Chapter V, the ethical codes of western 
nations are compared with the codes of other 
nations, and international dil'ferences 
are discussed. An inverse relationship 
between the 
stringency of ethical codes and the level of 
political freedom allowed by the government 
is 
observed. The impossibility of creating a 
standard ethical code, used by researchers 
in all 
nations and fields, is also described. 
Chapter VI contains the results from 
the 13 surveys returned (a response rate of 
50'r'o) 
and provides some analysis of these results. 
However, I 3 surveys are not an adequate 
sample 
from which to draw generalizations; 
another survey conducted on a larger 
scale is needed to 
confirm any trends from this survey. 
A summary of the first six chapters is in Chapter 
Vll, as well as conclusions and 
suggestions for future research. 
More research on the ethics of scientific 
publication in a historical and international 
perspective may provide a clearer view 
of the important issues in this field. Better 
solutions to 
ethical problems may be developed, 
which may eventually lead to a decrease 
in the rate of 
occurrence of ethical infractions and an increase 
in public trust in scholars and trust 
among 
scholars. 
CHAPTER II 
METHODS 
A comprehensive review of Internet and 
library sources published after 1950 was 
conducted to allow an understanding of the 
history of scientific publication ethics. The 
Internet 
search was conducted in September and 
October 2002 and January 2003 at www. google. 
corn 
with the query parameters "scientific 
publication ethics. 
" Over 30 relevant websites were 
returned. Many of the sites found at this stage 
were actually journal articles and contained 
references to similar articles. Wherever 
possible, journal articles found on the Internet were 
reviewed in paper. Both PubMed and 
MEDLINE were searched using the search 
parameters 
"scientific publication ethics" in October 2002 
and again in January 2003. Librarian Jeremy 
Hawpe from Texas AkM University's Sterling 
C. Evans Library was consulted in October 
2002. 
He provided assistance in searching 
numerous library databases, including the 
National Library 
of Medicine's (NLM) LOCATORplus database. 
Information from books written in the 
field 
and articles published in a variety 
of American, British, Canadian, and 
international journals was 
gathered and carefully reviewed. The 
published ethical codes from a number of 
professional 
organizations were also examined, in 
addition to the ethical guidelines prepared by 
many 
scientific journals. Several national codes of ethical 
conduct in science that included policies 
on 
publication ethics, from nations as 
diverse as Turkey and the U. S. , were also studied. 
Literature was included in the review 
it' it focused on one or more of the following 
five 
issues: peer review, authorship, conflict 
of interest, publication bias, or 
duplicate/redundant 
publication. Ethical codes and guidelines 
included in the review were those which 
dealt with the 
aforementioned issues; other guidelines were 
excluded. These issues were selected 
because of 
their prominence in the literature since 
1975. Other issues did appear, but with less 
frequency; 
these issues were therefore excluded 
from the review. A start date of 1975 was 
selected because 
literature on ethical practices in scientific 
publishing seems to have first appeared 
in quantity at 
that time. 
Materials were then grouped by topic for 
analysis. Ethical codes were analyzed 
separately. Articles were categorized by 
issue and then further organized 
chronologically. The 
articles were then compared and 
contrasted within their subgroups to 
develop a thorough 
understanding of each issue, and a timeline of important 
events was created. The timeline 
showed how ethical issues had developed. 
After analysis of the literature, 26 editors, 
authors, and peer reviewers were 
emailed an 
interview questionnaire. Interview subjects were 
selected from a variety of nations, including 
China, Canada, Great Britain, South 
Africa, 'Spain, Japan, France, the Netherlands, 
the U. S. , and 
Finland. The number 26 was chosen as an 
appropriate number of interviews to provide 
reasonably accurate information in a 
limited time period. Interviews were 
sent on January 27, 
2003, and a follow-up email was sent to 
those who had not responded by February 
22, 2003. 
Thirteen questionnaires were returned. 
Those interviewed were asked questions 
regarding their 
views on the ethical codes and guidelines 
currently in use. (See Appendix C. ) Interviewees 
were also asked how they believed 
the ethical climate in scientific publishing 
had changed over 
time. Information gathered from the 
returned questionnaires was examined 
to identify themes 
and patterns. 
The information gathered in the interviews 
was then examined along with that 
uncovered during the literature review. 
This compilation of literature sources and 
interview 
accounts forms the basis for this study. 
CHAPTER III 
THK ISSUES 
Over the past 30 years, five topics seem 
to have generated the most 
literature on the 
ethics of scientific publishing 
— peer review, authorship, conflict 
of interest, publication bias, and 
duplicate/redundant publication. An 
understanding of these issues is critical to 
examining both 
the historical progress of the literature 
and the ways various groups have 
dealt with the issues in 
crafling ethical codes. Authorship 
and conflict of interest appear to be 
areas of great cross- 
cultural difference as well as diversity 
of opinion among assorted scientific 
lields and 
organizations. Peer review and publication 
bias also seem to be serious issues 
for scientific 
journals and researchers in all fields, while 
duplicate/redundant publication is an issue 
that, while 
significant, has not produced much 
real controversy. Analyzing these 
issues and studying the 
viewpoints of different nations, publications, 
and professional societies is the 
first step toward a 
larger understanding of ethical issues 
in scientific publishing. 
Peer Review 
With well over 800 books and 
articles about it in print, peer review 
is by far the most 
heavily discussed issue in publishing 
ethics. Clearly, this is a subject of importance 
to many 
researchers. ' The ethical issue regarding 
peer review is not simply its 
effectiveness as a method 
of ascertaining the value of manuscripts, 
but rather which type of peer review is 
most ethical and 
practical. 
Peer review in publishing generally 
refers to the system used by most 
scientific journals 
to evaluate the scientific merit 
of manuscripts submitted for publication. 
Generally, editors send 
the manuscripts to one or more 
experts in the field that are not 
members of the journal staff. 
Unfortunately, it would be nearly 
impossible for an editor to have such 
extensive, detailed 
knowledge of all topics about which s/he 
publishes to determine the inerit 
of all manuscripts 
submitted. Historically, scientists 
discussed the results of their research 
with colleagues in 
writing before submitting that 
research for publication. However, 
as it became standard practice 
to assign credit for new discoveries 
to the first author to publish 
those discoveries, pressure to 
publish rapidly increased, and 
scientists submitted their research 
for publication without 
discussing results with colleagues. 
'" Since submitted manuscripts were 
no longer evaluated 
before submission and editors were generally 
not broadly knowledgeable enough to 
determine 
research merit unassisted, editors began 
to send the manuscripts out for evaluation 
after 
submission, in much the same way that 
authors had previously sent their work 
to peers belore 
publication. ' 
Over the years from the late 17th century 
to World War 11, this informal system 
slowly 
became standardized, and the formal 
process of peer review developed. Today's 
basic process 
is a system in which each submitted 
manuscript is not only reviewed by journal editors, 
but also 
sent out to one or more prominent 
researchers in that specific field. These peer 
reviewers 
identify strengths and weaknesses of the 
research and make a recommendation 
either for or 
against publication of the manuscript. At nearly 
all journals, editors make the final publication 
decision. 
ln practice, peer review is slightly 
more complex, There are three main types 
of peer 
review; closed, open, and blind. All 
three have been attempted by various 
scientific journals; 
opinions vary on which form of peer review 
is best. Each system has both positive 
and negative 
aspects. 
Most scientific journals use a system of closed peer 
review. ln this system, authors' 
names accompany the manuscripts sent 
for review and thus reviewers are 
aware of authors' 
identities. However, authors do not receive 
the names of the reviewers; the review is 
anonymous. One journal that uses this process is the 
New England Journal of Medicine. 
Although reviewers are asked to provide 
an evaluation of the manuscript, the editors 
stress that 
the final publication decision rests 
with the editorial staff. Little empirical 
research has been 
conducted on the closed review process, 
but it has been strongly supported by 
tradition since 
World War II. 
Nevertheless, this method of peer review is 
not without drawbacks. Reviewing 
articles 
takes time and is otten a thankless job. Closed system 
reviewers do not usually receive credit 
for 
individual reviews. At the same time, 
reviewers' anonymity shelters them from 
accountability 
for review quality. 
' Likely the strongest argument against 
a closed review system is that it is 
prone to abuse. With reviewer 
identities unknown, it is relatively easy 
for misconduct to occur. 
Such misconduct might include 
reviewers stealing ideas or attempting 
to hold up publication for 
personal gain. Several researchers have, 
in addition, questioned thc ethics 
of a system in which 
some identities are known while others 
are hidden. They argue that closed peer 
review is 
inherently unjust. 8 
A growing number of journals, such 
as the BMJ (formerly the British 
Medical Journal), 
are turning to open peer 
review. In this system, authors 
of submitted manuscripts are 
provided 
with reviewer identities and 
reviewers are provided with author 
identities. Some researchers 
consider this to be more fair than 
closed rev iew. 
" Some even go so far as to deem 
it "ethically 
superior. '" These individuals 
contend that the only ethical systems 
of peer review are those in 
which either all identities are 
known (open review) or no identities 
are known (blind review). In 
open review, authors are 
held accountable for their work, 
and reviewers are held 
accountable for 
the quality of their reviews. 
' There is even limited evidence 
to suggest an open system may 
produce higher quality reviews. 
" However, the research producing 
this evidence compared the 
reviews received under an open 
review system to those received 
in a blind review system. 
There 
does not appear to have been any 
study in which the reviews 
obtained under open review were 
found to be of higher quality when 
compared with those obtained 
through closed review (the 
most frequently used system). Also 
supporting an open review system 
is some researchers' 
assumption that authors would 
prefer it, ' but empirical 
research has not supported this. 
On the 
contrary, research suggests that 
authors' level of review satisfaction is 
based heavily on 
manuscript acceptance and not 
review method or quality. 
' More empirical research is 
needed to 
determine whether these bonuses 
truly exist. 
Along with the benefits of open 
review, there are several 
disadvantages. If reviewer 
identities were known, some 
researchers believe, reviews would 
be less critical. Reviewers 
might be leery of offending authors, 
they say, and relations 
between authors and reviewers 
might 
become strained. Ultimately, 
journal acceptance rates would rise 
significantly, and editors 
would be under greater pressure. 
" However, these negative effects 
are largely speculative. 
Studies have found that while there 
has been no discernible difference 
in review quality between 
open and closed systems, open 
review increases both the 
number of reviewers who decline to 
review manuscripts and the 
number of manuscripts reviewers 
recommend for acceptance. 
' ' 9, l 1, 13 
Realistically, the lack of difference in 
review quality appears to suggest 
that both methods are 
capable of producing reviews of 
equivalent quality. 
There is one remaining system 
of peer review — blind review. In 
a blind review system, 
both reviewers* and authors' 
identities are hidden. In practice, 
this system of peer review is 
often not possible. In studies 
of this system, 23'/0 to 42'/o of 
reviewers could correctly identify 
the authors based on the 
content and references. 
"" " 
Authorship 
Like peer review, authorship is the 
subject of much literature in publication ethics. 
While it was not uncommon to publish 
research anonymously in the 19 century, 
' this is 
certainly no longer the case. Because 
scientific credit is now often assigned based 
on first 
publication' and scientists are expected to 
take credit and responsibility for their 
work, 
anonymity is almost unheard of today. 
Authorship has become a major issue in many fields, 
and 
as of 1998-1999, authorship problems were 
the most commonly reported type 
of research 
misconduct. ' " 
Unlike peer review, authorship is not 
a single complex issue. Instead, 
authorship is the 
collective name for a family of issues, including: 
authorship credit, order of authors, group 
authorship, and honorary/ghost authorship. 
The most frequently debated of these issues 
is authorship credit, which in fact is 
often 
simply called authorship. There 
is at this time no single accepted 
method of determining what 
level of contribution to a project warrants authorship 
credit. The Guidelines for Good 
Publication Practice published in the 
COPE (Committee on Publication Ethics) Report 
1999 state 
that "as a minimum, authors should 
take responsibility for a particular 
section of the study. "" 
This same set of guidelines recommends 
that if no specific task can be attributed 
to a single 
person, that person should not 
receive authorship credit. These guidelines 
also suggest that all 
authors must take public responsibility 
for the content of the manuscript. 
" The American 
Chemical Society has less strict authorship 
requirements. In the January 2000 revision 
of its 
Ethical Guidelines to Publication of 
Chemical Research, the American 
Chemical Society states 
that "all persons who have made 
significant contributions to the work 
reported and who share 
responsibility and accountability for the 
results" ' should be listed as authors. 
Although this may 
appear to be the same statement, 
the American Chemical Society does 
not define "significant 
contribution" and holds researchers 
accountable solely for the results of the research 
and not for 
the paper as a whole. This type of guideline 
in some cases enables typists and 
assistants who 
performed only technical tasks to be 
granted authorship credit' and in 
other cases allows 
supervisors who had little to do with the 
actual research to receive authorship 
status. 
" Partially 
in response to this sort of authorship abuse, 
the International Committee of Medical 
Journal 
Editors created the Uniform Requirements 
for Manuscripts Submitted to 
Biomedical Journals, 
' 
which is today used by many biomedical 
journals. (As of 1997, there were just over 
600 
biomedical journals that followed the Uniform 
Requirements. ) ' The Uniform Requirements 
make the following statement about 
authorship: 
Fach author should have participated 
sutTiciently in the work to take public 
responsibility for the content. Authorship 
credit should be based only on 
substantial contributions to (a) conception and design, 
or analysis and 
interpretation of data; and to (b) drafting the article or 
revising it criticagy for 
important intellectual content; and 
on (c) final approval of the version to be 
published. Conditions (a), (b), and (c) must all be met. 
" 
Order of authors is also an important issue. 
When a study has multiple authors listed, 
this order might be used to determine 
to whom comments should be directed 
or which researcher 
made the largest contribution. However, 
because of the incredible diversity of convention 
among various fields and organizations, 
many journals, such as the BMJ, suggest that 
readers 
"should infer nothing from the order of authors. 
" In some fields, it is common for authors 
to be 
listed alphabetically. At other times, 
authors are listed in order of greatest contribution. 
In still 
other circumstances, a group of researchers 
working on several projects will rotate the order 
of 
authors from publication to publication, 
thus ensuring that each member of the group 
is listed 
first on at least one manuscript. Although 
emphasis is sometimes placed on order 
of authorship 
(Often authors listed fourth or later are not 
included in citations, and sometimes only 
the first 
author is listed as in "Smith et al. "), these varying practices 
render order of authorship irrelevant 
in many cases. 
A major difhculty with order of authorship 
appears to stem from another issue: 
group 
authorship. As more and more research 
is performed by large groups of researchers, 
lists of 
authors become longer and longer or 
are replaced altogether with the 
name of the research group. 
This has caused diAiculties with indexing 
and citing such papers' and with 
determining levels 
of contribution and accountability. 
' This problem seems to be growing, 
and as yet there does 
not appear to be any solution. 
The final issue in the authorship 
family is honorary/ghost authorship. 
Honorary 
authorship is listing as an author an 
individual who does not meet authorship 
requirements; ghost 
authorship is failure to list as an author 
an individual who does meet authorship 
requirements. 
Most recently, a 1998 study by Flanagin, 
Carey, Fontanarosa, et al. of review articles 
published 
in six medical journals found that 26% of the 
articles likely listed honorary authors 
and I 0% 
10 
likely had ghost authors. 
' Other studies have found similar results. 
' ' This suggests that abuse 
or neglect of authorship guidelines is fairly common. 
Conflict of Interest 
A third issue of concern in publication ethics is conflict 
of interest. It is not the 
existence of conflicts of interest, however, that is ihe issue; 
the issue is whether, and if so, when, 
the conflicts of interest should be disclosed. Broadly, 
conflicts of interest are any conflicts 
which may influence (but do not necessarily infiuence) the 
judgment of authors, editors, or 
reviewers. More specifically, conflicts of interest in scientific 
publication include financial, 
political, academic or personal conflicts that 
have the potential to influence a researcher's, 
editor' s, or reviewer's work. Financial conflicts appear 
to be of greatest concern to most 
scientists and may include: employment or past 
employment with a company that will be 
affected by the outcome of the research, work as a 
consultant for such a company, or other 
monetary awards provided by such companies. 
Numerous ethical codes and guidelines advise the 
disclosure of all conflicts of interest, 
especially financial conflicts. 
"""""' However, there are researchers who believe that 
disclosing a conflict of interest has a negative effect on 
readers. These researchers state that 
disclosure creates a bias against the author, leads 
readers to believe that researchers may be 
dishonest, and prevents the research from being 
fairly evaluated. 
' New England. Journal of 
Medicine editors Kassirer and Angell refute this 
argument by stating that disclosure requirements 
do not necessarily question the honesty of authors, 
but instead aim to alert readers to possible 
unconscious bias. 
' Critics of disclosure stress that financial conflicts of 
interest are not the only 
type of conflict of interest and that disclosure 
focuses too much on these financial conflicts while 
ignoring other types. 
" On the other hand, supporters state that 
financial conflicts of interest are 
of greater concern because financial conflicts are both 
"voluntary" and "seductive", they say that 
other forms of conflict, such as the desire to find 
positive and influential results, are inherent to 
the research process. 
36 
Publication Bias 
lt is widely believed that studies reporting 
positive results are more likely to be 
published than studies with negative results. 
This publication bias is assumed because journals 
appear to publish more studies with positive 
results than with negative results. 
" Certainly 
12 
appear to have been duplicated. 
' Although many journals require that researchers submit 
copies of all related articles previously published or in press, 
it is clear that this requirement is 
not always followed. However, computerized 
medical indexes and databases may be making 
future duplicate/redundant publication much more 
difficult. 
13 
CHAPTER IV 
HISTORICAL HIGHLIGHTS AND 
TRENDS 
When comparing past with present, 
especially in a fairly subjective field such 
as ethics, 
it is easy to think nostalgically 
about how much better the past 
was. A hundred years ago, a 
news article claiming that a researcher 
failed to declare a conflict of interest 
would have been 
scandalous, if it had been printed at 
all. Today, seeing such an article 
in the news section of a 
major scientific journal is common. 
Conflict ol interest is now a major subject of 
publication, 
not only in journal articles, but in many 
different media forms. Artides 
discussing and debating 
the ethics of the peer review system 
or proper authorship practices 
are also regularly printed. 
Even 50 years ago, such articles 
were rare. However, this does not 
mean that these issues are 
new, Although it is mainly in 
the last 30 years that ethical issues in 
publishing have been studied 
and appeared in print, it seems 
likely that many of them existed 
since shortly aller or possibly 
even before the first scientific 
journal was published. Tracing the 
development of these issues 
over time and examining the key 
steps that have led to the 
current understanding of them may 
facilitate future progress and 
solutions. 
Origin of the Scientific Journal 
Before the late 17a century, 
scientists such as Isaac Newton 
zealously guarded their 
research, unwilling to share their 
work with colleagues for fear 
that their discoveries would be 
stolen. Those scientists who did 
wish to share their research 
did so at their own risk. 
' Although 
sharing was a gamble, it was 
also vital to the growth of scientific 
knowledge. However, for 
many scientists, the advancement 
of science was worth thc risk of 
losing credit for their 
discoveries. 2 
With no medium available for 
publicly disseminating new 
discoveries, scientists turned 
to private means. Scientists 
frequently exchanged correspondence, 
describing their recent 
experiments and results in Latin. 
The use of Latin conquered language 
barriers and allowed 
information to be shared among 
scholars of difl'erent nations. 
' 
The practice of scholarly letter-writing 
was so prevalent that over the 
course of a 
lifetime, many scientists wrote 
and received hundreds of letters. 
In several cases, researchers 
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published collections of the letters they 
had written; one Danish physician, 
Thomas Barthotin, 
published five volumes of his own 
correspondence and had plans to publish 
three more before 
the letters were ai:cidentally 
burned. ' 
Unfortunately, there was as yet no way 
to prevent unethical researchers 
from stealing the 
work of their more ethical fellows. To 
provide credit where credit was due, 
Henry Oldenburg, 
secretary of England's Royal Society of 
London, promised to publish 
scientists' works and 
defend the claim of the first published 
author. ' Thus the first scientific journal, 
Philosophical 
Transactions, was published in 1665, and 
the field of scientific publishing was 
created. ' 
Although Oldenburg was the secretary 
of the Royal Society of London and 
articles 
written for Philosophical Transactions 
were sometimes reviewed by Society 
Fellows prior to 
publication, Philosophical Transactions 
was not officially sponsored by 
the Royal Society of 
London until the middle of the 
18'" century. In fact, scientific journals in the 
17e and 1 go 
century were rarely sponsored by 
scientific societies, unlike modern journals, 
of which many 
receive formal sponsorship. 
The first scientific journals differed from 
modern journals in several other ways as 
well. 
Early journal editors often referred to 
themselves as the journal's author and personally 
wrote 
much of the journal's content. These journals 
rarely lasted more than two 
or three years, likely 
because of the strong tie between the 
journal and its author/editor. Duplicate/redundant 
publication, a common occurrence 
in the 17" and 18'" centuries, was 
not viewed negatively until 
the end of the 19 century. In the early 
days of the scientific journal, duplication 
was not a 
concern because readers rarely had 
access to more than one journal. Today, 
with a variety of 
journals widely available, duplicate 
publication is seen as a misuse of journal space. 
Calls for Research and Reform 
Even though ethical issues likely 
began to arise shortly after the 
first scientific journals 
were created, it appears that these 
issues were not discussed in the 
literature, and therefore, there 
appears to be no record of ethical 
issues prior to the 20'" century. 
For example, while there is 
documentation describing a peer 
review system very similar to 
today's closed review system 
from one 17'" century French 
journal, there does not appear to be any 
discussion about this 
system. After World War 11, 
however, peer review became a 
topic of much debate in the 
scientific community. This debate 
took the form of numerous opinion 
articles, both for and 
against the peer review process, 
but no empirical studies had 
been conducted to ascertain the 
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value of the process. What appears to 
be the first published call for 
research on peer review 
appeared in the New England 
Journal of Medicine in 1985. 
' The result was an explosion in 
published material on peer review 
and the First lntemational 
Congress on Peer Review in 
Biomedical Publication. As of 2002, 
articles on peer review were being 
published at a rate of 
170 to 200 articles per year. 
' 
Another ever-present ethical issue 
in publishing that has been 
discussed mainly for the 
last 50 years is authorship. Before 
the Renaissance, there was no 
real notion of intellectual 
property rights in science. Thus, 
authorship was no real issue. During 
the Renaissance, the 
concepts of humanism and individuality 
werc developed and carried into 
all aspects of life, 
including science. Researchers began 
to form ideas about ownership 
and credit. This led to the 
concept of authorship. For some time 
during the 18 and 19 centuries it 
was not uncommon 
for researchers to publish their 
work anonymously, mainly 
because there was a common idea 
that only well-known scientists 
should link their names with their 
works. By the 20' century, 
however, this practice had fallen 
out of favor in the scientific community 
as researchers were not 
only expected to receive credit 
for their research but also to take 
public responsibility for it. As 
research projects became larger and more 
expensive following World War 11, 
large groups of 
scientists became necessary in 
fields like particle physics and 
biomedical research to complete 
experiments. The result of these group 
experiments is the multiauthored 
study, which has 
become more and more prevalent. 
As the number of authors has increased, 
so, it seems, has the 
number of authorship issues. 
However, authorship was only rarely 
discussed in the literature 
until the 1970s, except for discussion 
in relation to indexing and 
cataloguing published works. 
In the 1980s, ethical codes published 
by the American Chemical 
Society, the American 
Psychological Association, the 
Council of Biology Editors, the 
International Committee of 
Medical Journal Editors, and other 
professional societies included sections 
detailing specific 
ways to deal with authorship 
issues. ' Huth and Relman 
started writing about authorship 
in the 
early 1980s (see Appendix A: Bibliography), 
and empirical studies of the effects 
of authorship 
abuse and possible solutions to 
authorship problems have been 
conducted at least since 1990. 
Today, authorship is a topic 
of fairly regular publication, with 
dozens of articles published 
annually. 
Other issues of publishing ethics seem 
to have become topics of concern 
only in the last 
50 years. Historically, scientists 
conducted research to expand the 
body of scientific knowledge 
and were generally funded by 
universities, scientific societies, and 
the government, and 
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occasionally out of their own pockets. Since World 
War II, however, many studies have been 
funded by private corporations. With 
this movement of science into the business 
sector, it is not 
surprising that conflict of interest has become an 
issue of increasing importance in scientific 
publishing, 
' Beginning in the mid 1980s, conflict of interest 
scandals have been reported not 
only in specialized scientific journals, but in more 
widely known scientific publications such 
as 
Science and Nature. 
' " By the late 1980s, many journals had adopted 
conflict of interest 
policies, and ethical codes published by many 
professional societies had begun to advise 
disclosing conflicts of interest, particularly financial 
conflicts. " Despite some claims made 
beginning in the early 1990s that disclosure 
leads to mistrust and is equivalent to 
censorship, ' 
articles and ethical codes published to date appear 
to call for disclosure more and more often. 
Another issue that has appeared in the 
literature more often in the last 15 years is 
publication bias. Since the late 1980s, the 
possibility of bias against negative results has 
come 
up repeatedly in journal articles. To date, there 
appears to be little evidence suggesting 
that 
publication bias is a real problem. Many 
scientists seem to believe that publication 
bias exists, 
but studies indicate that high quality 
experiments with negative results are simply 
submitted less 
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oflen than experiments of equivalent quality 
with positive results. 
Unlike peer review and authorship issues, 
which seem to have existed to some degree 
since the creation of the scientific journal, 
duplicate/redundant publication is a relatively 
new 
issue. As previously mentioned, 
duplicate/redundant publication was not 
considered 
inappropriate in the first centuries of journal publication. 
As the availability of scientific 
journals and the volume of new knowledge increased, 
repeated publication eventually became 
a 
problem. Until 1980, however, very little was 
said about this issue. 
' Since the first recognition 
of duplicate/redundant publication as an issue, 
a number of studies have been reported 
starting in 
1989 that address the prevalence of the problem. 
Estimates of the rate of occurrence of 
duplicate/redundant publication range from 8. 
500 to about 20'/0 but do not appear to 
have 
increased or decreased substantially over 
time. This suggests that although the 
problem is not 
growing, it is not diminishing either, 
The Literature 
Starting in the 1980s, books and articles 
on publishing ethics have appeared 
in the 
scientific literature with regularity. As the supply 
of articles focusing on these issues grew, 
scientific publishing ethics became its own 
genre. Certain authors became leaders 
in their 
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specialized ethical fields. Which 
publications and authors have 
had the greatest impact on 
publishing ethics can be seen 
most clearly not only by 
examining the texts themselves, 
but by 
observing the frequency with 
which certain publications and 
authors are cited by others. 
The 
following publications and 
authors appear to have been 
the most influential in 
publishing ethics 
based on these criteria. 
In 1985, the first edition of 
Lock's book A Dificult Balance: 
Editorial Peer Review in 
Medicine ' was published, Although 
this book deals solely with 
the peer review process in 
medical publishing, it was apparently 
the first comprehensive study 
of peer review in any field. 
A Difficult Balance contains 
most of the information known 
about peer review at that time 
and 
was one of the first publications 
about peer review not exclusively 
based on opinion. 
Another book that contributed 
greatly to the body of knowledge 
in publishing ethics was 
Ethics and Policy in Scientific 
Publication, ' published by the 
Council of Biology Editors in 
1990. The first part of this book 
contains information gathered 
from two surveys. The surveys 
were sent to the members of the 
Council of Biology Editors and 
contained questions about 19 
topics in publishing ethics. 
The surveys presented 19 
scenarios and asked whether 
similar 
situations were a problem and 
how often they occur, as well 
as what solutions respondents 
recommended. More than 200 
responses to each survey were 
received. The second part of the 
book contains transcripts of 
proceedings and open discussions 
held at a Council of Biology 
Fditors conference in October 
1988. This is one of the largest 
collections of opinion on ethical 
issues in publishing available 
and has provided much 
valuable information that is 
diflicult to find 
elsewhere. 
In addition to these two 
books, many articles have been 
widely cited in the literature 
on 
scientific publishing ethics. A 
relatively small number of authors 
wrote the majority of these 
articles. Rennie is one of the most 
prominent; his numerous 
articles cover peer review, 
authorship, conflict of interest, and 
publication bias. Angell and 
Kassirer, frequent collaborators, 
have written several important 
articles on peer review, authorship, 
and conflict of interest. 
Huth's articles on authorship, 
conflict of interest, and duplicate/redundant 
publication are also 
widely cited, as are Relman's 
articles on the same issues. 
Flanagin's articles on authorship, 
conflict of interest, and publication 
bias are fairly well-known, as 
are Dickersin's studies of 
conflict of interest and publication 
bias. Horton has been particularly 
important in the areas of 
authorship and conflict of interest, 
and Lock has greatly influenced 
both peer review and 
authorship. Garfield, another 
prolific author, has been writing 
about authorship and conflict 
of 
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interest since the late 1970s. Additionally, van 
Rooyen, Godlee, Smith, and McNutt have 
published important empirical studies of peer 
review, and Olson, Weber, Callaham, and 
Wears 
have produced empirical data on 
publication bias. Interestingly, most of these 
authors are 
associated with biomedical journals and research. See 
Appendix A (Bibliography) and 
Appendix B (Recommended Readings) for examples 
of works by these authors. 
The International Peer Review Congresses 
ln 1983, Bailer and Patterson called for 
empirical studies to be conducted on peer 
review. " In response, the editors of the Journal vf 
the American Medical Association (JAMA) 
issued an invitation to readers in 1986, asking 
researchers to attend a peer review congress. 
The 
purpose of the congress would be to present 
as yet nonexistent empirical studies 
of peer 
review. " The First International Peer 
Review Congress was held in Chicago in 
1989. Since 
that first congress, the scope of these congresses 
has expanded to cover any topic of relevance 
in 
scientific publishing, including ethics, 
operations, and legal issues. Hundreds of articles 
on these 
issues have been published since 1989, and 
increases in articles on ethical issues have 
been seen 
even in noncongress years. 
' At that first congress, peer review 
was the focus; 50 papers were 
submitted for presentation. 
" Peer review was not the only issue 
discussed at the congress, 
however. Three studies focusing on 
publication bias 
' were also presented. Based on the 
papers presented at the congress, 
JAMA published a theme issue, focusing 
solely on ethical 
issues in scientific publishing, especially 
peer review. 
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Based on the success of the first congress, a 
Second International Peer Review Congress 
was held in 1993, also in Chicago. One 
of the more compelling presentations made at 
this 
congress was by Kassirer and Campion, 
who discussed manuscripts presented 
at the first 
congress. They stated that most of the work 
previously presented dealt with the way 
in which 
editors manage manuscript and peer review 
or with the history or philosophy of peer 
review. 
They argued that management was 
not the area in which research was 
needed, but that research 
should be conducted to study manuscript 
assessment, or the process through which 
reviewers 
evaluate manuscripts. At this congress, 
too, few presentations were based on 
manuscript 
31 
assessment. For example, Gilbert, Williams, 
and Lundberg presented a study of possible 
gender 
bias in peer review, 
' and Glantz and Bero gave a presentation 
on selecting appropriate peer 32 
reviewers for grant review processes, 
both management issues. . 33 
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At the Third International Peer Review Congress, in 
Prague, Czech Republic, in 1997, 
publication bias was once more a major theme. 
' Dickersin et al. reported on an apparent bias 
against selecting female editorial staff members. 
" Other researchers presented evidence 
suggesting the possibility of bias in favor of articles from the 
United States and articles written in 
English, " but one of these studies did not adjust for quality 
differences, " and the other was 
conducted before the journal studied had finished introducing pertinent 
quality control standards 
now in place. The most thought-provoking reports 
on publication bias at the 1997 congress 
were the three presentations which seem to confirm 
the existence of bias against negative 
results. Callaham and colleagues examined abstract 
acceptance to scientific meetings and 
found that there appeared to be a bias against abstracts 
showing negative results. 
" This was the 
only study of the three that appeared to truly confum 
publication bias. Another of these studies, 
presented by the same group of researchers, focused on 
authors' failure to publish manuscripts of 
studies with negative results alier presenting these 
manuscripts at scientific meetings. 
3B 
However, if publication is defined broadly to include any 
communication of results, ' then these 
studies had, in a sense, already been published. 
Misakian and Bero considered failure to publish 
insignificant results a bias in their study, 
'"' 
when in fact it is often an editorial decision. Every 
study cannot be published, and generally studies 
with significant results should take precedence 
over those with insignificant results. In all, 
JAMA*B third theme issue on peer review published 
33 articles on a variety of subjects, focusing on publishing 
issues important to clinical 
researchers. 3 
Most recently, the Fourth International Congress 
on Peer Review was held in Barcelona, 
Spain, in September 2001. This congress was somewhat 
disrupted by the terrorist attacks on the 
World Trade Center and the Pentagon in the U. S. a few days 
before, which made travel difficult 
or impossible for many congress participants from 
the Americas. Despite this disruption, the 
congress was deemed a success as 40 of 43 presentations were 
given as scheduled, and 58 of 65 
posters were displayed. 
' While most studies presented still focused on management 
issues, ' 
Horion presented a small study examining the 
relationship between author opinions and opinions 
presented in research papers. He found that many 
papers do not represent the views of all listed 
authors. In addition to peer review and authorship 
issues, the Fourth International Peer Review 
Congress concentrated on publication bias, postpublication 
criticism, quality standards, and legal 
issues. JAMA's fourth theme issue contained 32 papers 
presented at the congress, including 
three on lniernet publication. 
' 
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Ethical Codes and Guidelines 
By the 1980s, peer review, authorship, 
conflict of interest, publication bias, and 
duplicate/redundant publication had become prominent 
issues in publishing ethics. The more 
literature appeared on these issues, the more 
solutions were suggested to rectify problems. 
Authors frequently disagreed about solutions, 
and as previously discussed (see Chapter 3), issues 
became more and more complicated. A need was 
perceived for statements describing how to 
handle these issues when they arise. In response, 
several scientific prol'essional societies and 
groups of editors published ethical guidelines. The 
professional societies seem to have led the 
way; their guidelines began appearing 
in the early 1980s. These guidelines were not 
complete, 
however, and provided guidance only in certain 
areas — exactly which topics were covered 
varied from society to society. Groups of editors began 
to publish ethical codes at about the 
same time, but were more thorough. These codes 
tend to be much longer and cover the issues in 
much greater depth. The Uniform Requirements 
for Manuscripts Submitied to Biomedical 
lournals, which was first published in 1979, seems to 
be one of the most influential and widely 
used of such codes. By 1990, journals began including policy 
statements on these issues in their 
guidelines for potential authors. Although this 
abundance of guidelines may at first appear 
helpful, this is not necessarily the case. The 
fact that these issues continue to be problems 
afler 
published guidelines have been plentiful and 
readily available for more than 10 years suggests 
that authors are unaware of these guidelines, confused by 
the many different methods suggested 
for handling ethical issues, or blatantly ignoring 
ethical practices. Assuming that most scientists 
behave ethically, it seems likely that lack of awareness 
and confusion are the main causes of 
continuing ethical problems. 
Some of the earliest ethical codes were published by 
professional societies in the 
sciences, such as the American Psychological 
Association in 1983' and the American Chemical 
Society in 1986. These societies and others created 
ethical guidelines in publishing at least 
partially out of a sense of duty to provide guidelines 
to their members. As stated in the 
American Chemical Society's 2000 revision of the 
Ethical Guidelines to Publication of Chemical 
Research: "An essential feature of a profession is the 
acceptance by its members of a code that 
outlines desirable behavior and specilies obligations 
of its members to each other and to the 
public. "" Although these early guidelines 
did provide vital ethical information to 
scientists 
within these professions, these guidelines 
were rather incomplete. The American 
Psychological 
Association's 1983 guidelines discussed peer review, 
authorship, duplicate publication, and 
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plagiarism, but provided no information 
on conflict of interest or any other ethical 
issues in 
publishing. ' The American Chemical 
Society's 1986 guidelines provided codes of conduct 
regarding all five major issues in publishing ethics, 
especially duplicate/redundant publication, 
but are fairly brief and lack details, giving 
no examples and little elaboration on 
the issues. 
Both of these professional societies have updated 
and expanded their ethical codes since 
the 
1980s, the American Psychological Association 
most recently in 2002" and the American 
Chemical Society in 2000. 
" 
About the same time as professional 
societies published their first ethical codes, groups 
of editors created the first comprehensive codes 
of ethical policy in scientific publication. In 
1983, the Council of Biology Editors included 
in the 5 edition of its style manual a large 
section 
on ethical issues, including all five main 
issues and many other topics. 
" ln 1979, the 
International Committee of Medical Journal 
Editors wrote the Uniform Requirements 
for 
Manuscripts Submitted to Biomedical Journals. 
This document is quite thorou@ and complete; 
it contains information on nearly every 
issue in publishing ethics, including the 
five main issues. 
The Uniform Requirements have been well 
received since publication; more than 600 journals 
worldwide used these requirements in 
addition to their own instructions for authors 
as of 
1997. "' One possible difficulty with such detailed 
guidelines is that readers may become 
bogged down in the tremendous amount 
of information. Another possibility is that 
scientists 
simply do not use the guidelines for 
ethical purposes because ethics is not the 
main focus of the 
document; ethical guidelines are buried 
amongst guidelines for manuscript preparation 
and are 
therefore not as easy to access as professional 
society codes. One group of editors that has 
produced a more accessible set of guidelines as part 
of its annual report is the Committee on 
Publication Ethics (COPE). COPE was first formed in 
1997 out of "[concern] about the lack of 
clear guidelines on how to deal with breeches 
of research and publication ethics in [an] editorial 
capacity. " The first report, issued in 1998, 
included relatively brief sections on a variety 
of 
issues in publishing ethics, including study 
design and ethical approval for experiments 
on 
human and animal subjects, data analysis, authorship, 
conflicts of interest, peer review, 
redundant publication, plagiarism, duties 
of editors, media relations, and advertising. 
COPE has 
since issued a report every year, most 
recently in 2002. 
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By 1990, many major scientific journals 
were publishing their own ethical policies 
as 
part of their information for potential 
authors. Science, iVature, the Journal of the 
American 
Medical Association, the New England 
Journal of Medicine, and the BMJ all have policy 
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statements dealing with ethical issues. 
These and other journals also pass along 
information on 
ethical issues to authors through 
editorials. 
Although the wealth of information available 
on publishing ethics has likely 
increased 
awareness of the issues, it remains unclear 
to what extent this has ameliorated 
the problems. 
Looking ahead, it seems that as 
awareness grows and education 
increases, occurrences of these 
problems will decrease. However, 
it seems unlikely that ethical 
problems in scientific 
publication will ever disappear 
completely. 
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Figure 1 
Timdirte ofEvertts in Scietttinc 
Ptthhsiting Ethics 
2001: Fourth International Peer Rev 
iew Congress in Barcelona 
1997: Third 
Intemahonal Peer 
Review Congress in 
Prague over 600 
ioumals follow Und'orm 
equirements; Committee on 
Publication Ethics formed 
1990: empirical studies of authorship 
abuse published; Council of 
Biology Editors publishes 
1INics ctnd Policy in Scientific 
Publication 
1989: 1st studies of duplicate/redundant 
publication; First 
International Peer Review Congress in 
Chicago 
1988: Council of Biology Editors 
hosts conference on 
ethics and policy in scientific 
publication 
Late 1980s: publicatian bias 
appears as an issue 
1986; JA/Vtt issues invitation to 
1st peer rev iew 
congress; American Chemical 
Society creates 
ethical guidelines in publishing 
1985: Lock publishes A Dificult 
Bcdonce: 
Btdtorial Reer Reste w in Metdcinc 
1983: Bailer snd Patterson cali for 
empirical study of peerreview; 
American Psychological 
Association publishes 
ethical guidelines far 
publishing, Council 
af Biology Editors 
includes ethical 
issues in style 
manual 
Mid 1980s: conflict of interest scandals 
reparted 
Early 1980s: Huth and Relman begin 
writing about authorship 
1980: duplicate/redundant publication 
becomes an issue 
1979: Unifann Requirements published 
1950 to the present: peer review 
Mated in scientific cammunity; 
authorship issues first acknowledged 
18th and 19th centuries: many 
scholars publish anonymously 
Late 17th century: French jaumal uses system 
similar to closed peer review 
1665: 1st journal, Pbdosophtccd 
Ilrtnroctlortr, published in London 
Early 17th century: Latin c orrespan 
dence among scholars 
1998: 1st COPE(Committee an Pubi ication 
Ethics) 
Repart published 
1993: disclosure policies labeled 
McCardtyism; Secand International 
Peer 
Review Ccngress in Chicago 
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CHAPTER V 
INTERNATIONAL COMPARISONS 
AND THE IMPOSSIBILITY OF 
STANDARDIZATION 
Among nations, there are many 
ways of viewing some of the 
ethical issues previously 
discussed. Some practices thai 
would be considered unethical 
in Britain or the United 
States, 
two countries which appear 
to have similar ideas about 
scientific publishing ethics, may 
be 
acceptable in other nations, and 
practices acceptable in China may 
not be appropriate in Canada. 
Peer review, authorship, and 
duplicate/redundant publication are 
all understood differently 
in 
different countries. As stated 
in the introduction to the 
1999 COPE (Committee on 
Publication 
Ethics) Report, ethical guidelines arc 
meant to be "advisory" rather 
than "prescriptive. 
"' This is 
because of the nature of ethical 
issues: Ethical problems are 
those problems which do not 
have a 
simple solution, but involve 
choosing between competing 
values. Publication bias, for 
example, 
is an ethical dilemma; an 
editor may prefer to publish 
studies with positive results 
because these 
results will appear more 
significant to readers, but studies 
with negative results also 
need to be 
published, in part to prevent 
scientists from repeating studies 
needlessly. All ethical issues 
involve such clashes between 
competing values, and while 
one society may choose one 
method 
of handling an issue, another society 
may choose another method. 
Although different, both 
methods may be equally valid. 
Just as different nations have 
different views on ethical issues 
in scientific publishing, 
they also have different 
means of monitoring ethical 
publication practices. In many 
societies, 
ethical practices are regulated by 
the government. In these 
and other societies, scientific 
and 
other organizations sometimes 
also provide guidelines on 
ethical practices. In some cases, 
these 
organizations require their 
members to follow these guidelines, 
while in others, the final 
decision 
on how to handle ethical 
dilemmas is left to the individual. 
Many countries have 
implemented 
systems that combine private 
guidelines with government 
control, while others appear 
to have no 
control whatsoever. In general, 
it seems that the type of 
government — democratic, 
socialistJcommunist, or authoritarian 
— determines the manner in which 
ethical publication 
practices are regulated. In fact, 
it seems that the more 
political freedom a country enjoys, the 
less likely it is that the 
government will regulate 
ethical practices and vice versa. 
In other words, 
25 
an inverse relationship exists between 
political freedom and government regulation 
of publishing 
ethics. 
Western Industrialized Nations 
Most industrialized nations in the West 
monitor ethical practices in scientific publishing 
through a combination of government regulations 
and guidance from private organizations, 
with 
private organizations generally more 
active. Countries that qualify as western 
industrialized 
nations base their economies mainly on 
industry rather than agriculture, share 
some basic 
cultural values with the nations of Western Europe, 
and often have some form of democratic 
government. These countries include Australia, 
Canada, France, Germany, Great Britain, 
the 
Netherlands, and the United States. 
These countries typically have laws regulating 
the ethical conduct of research which 
include sections on ethical publication 
practices. However, these sections rarely 
look at the 
issues in depth, and frequently only cover 
a few key issues while ignoring other 
less prominent 
issues. For example, in the United States, 
the OtTice of Research Integrity, part of the U. 
S. 
Department of Health and Human Services, has 
published policies on "instruction in the 
responsible conduct of research. 
" These policies deal with the ethical 
conduct of research and 
with three ethical issues in scientific publishing: 
peer review, responsible authorship, 
and 
conflict of interest. Each of these issues is defined 
in a brief paragraph, but no detailed 
information is given, and the only specific 
recommendation made is that researchers should 
be 
educated on these issues. In Australia, the 
National Health and Medical Research 
Council 
(NHMRC) has created guidelines on research practice 
which are intended to "guide institutions 
in developing . . . procedures and 
guidelines by providing a comprehensive 
framework of 
minimum acceptable standards. 
"' The NHMRC requires scientific institutions 
to have "clearly 
formulated policies" on publications, authorship, 
and conflict of interest. It then describes the 
minimum requirements for guidelines on these 
issues. Less than a page is written about 
each 
issue. Other western industrialized nations 
have adopted similar policy statements. 
" These 
policy statements are generally advisory, 
not prescriptive. Even when the policies 
"require" that 
institutions follow their recommendations, 
the only penalty for not doing so appears 
to be the 
dim possibility that the government 
unit issuing the policy will refuse to fund 
research conducted 
by that institution. Although 
there are a few government agencies in 
western industrialized 
nations which offer more comprehensive 
guidelines, there do not appear to be any 
western 
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nations which provide strict regulations 
for scientific publishing ethics. More 
detailed guidelines 
on ethics in scientific publication 
are found in statements and manuals 
produced by private 
organizations. A number of these organizations 
are discussed in Chapter IV. 
This method of monitoring ethical practices 
in scientific publication may seem 
fairly 
loose, but it is closely tied to the 
democratic tradition under which most 
of these countries 
operate, In a democracy, "supreme 
power is vested in the people and 
exercised by them. 
'+ 
Therefore, it is logical that private 
organizations and not the government 
bear the responsibility 
for providing comprehensive guidelines 
on scientific publication ethics. 
Other Nations 
Many countries outside the West 
have other methods of monitoring ethical 
practices in 
scientific publication. Some of these nations 
appear to offer almost no guidance 
whatsoever 
outside of contract and copyright law. 
Frequently, private organizations in 
these nations appear 
to have limited roles in the creation 
of policy. These countries are usually 
either 
nondemocracies, developing nations, or 
both. Nondemocracies include 
communist and 
authoritarian nations. Developing 
nations include several recent 
democracies and are those 
countries which still depend largely 
on agriculture for economic survival. 
Unlike western industrialized 
nations, nondemocracies appear to 
hardly monitor 
publication ethics at all. Relevant 
government regulations in countries 
like China focus almost 
entirely on patents, trademarks, copyrights, 
and contracts, 
' with little or no acknowledgement 
of 
ethics aside from international 
informed consent laws. Because the 
Chinese government does 
not appear to have any policies on 
ethical issues in scientific publication, 
individuals, journals, 
and associations have stepped in 
to fill this void. In China, the main 
issues of concern are peer 
review and authorship. Since 1990, a peer 
review system for research has been 
slowly replacing 
China's previous "planned economy" system 
(in which researchers are given projects by 
the 
government). Authorship is also becoming 
an issue of growing concern since the 
idea of 
intellectual property rights has taken 
hold in China largely since 1995. 
" 
This system of government unconcern 
toward ethical issues in scientitic 
publication 
seems at first surprising from a 
communist government. Aller all, a 
communist government is 
one in which "all economic and social 
activity is controlled by a totalitarian 
state. " However, it 
is unnecessary to regulate publication 
ethics in a state in which the government 
maintains 
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complete control over research. 
With such intense government scrutiny 
in such an environment, 
regulations seem superfluous. 
Developing nations, whether they are 
democracies or not, appear to otTer limited 
guidance on ethical practices in 
scientiiflic publication. Although India, 
for example, has a 
centuries old tradition of ethical practices in 
medical research, it seems that this 
tradition is not 
upheld in India today, 
" It also appears that Indian journals are doing 
little to assist authors in 
understanding ethical issues in scientific 
publication. Indian journals print few notices 
informing 
authors and others of these issues; publication 
bias seems to be one issue that is 
discussed rarely 
if at an. "'4 
Like China, India appears to largely 
ignore ethical issues in scientific 
publication. It 
appears that developing nations 
often do not monitor ethical issues simply 
because they are 
lacking in personnel and infrastructure 
to do so. Many of these countries are quickly 
moving 
toward industrialization and have not 
had time to adjust to such rapid growth. 
Regulations will 
likely develop over time as these 
nations become more industrialized. 
International Differences 
The variety of methods used to monitor 
ethical practices is only one difference 
in how 
countries view issues in the ethics of 
scientific publication. Another difference 
emerges in peer 
review In western cultures, there 
was some type of peer review system 
in use even before the 
first scientific journal was published. 
" Peer review in the West has been 
described as a "crucial 
democratization of the editorial process . . . 
lessening the impression that editorial 
decisions are 
arbitrary. "' However, in some 
nonwesteni countries, peer review has 
only recently been 
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adopted. In these countries where peer 
review processes are relatively new, 
the peer review 
system is not viewed in the same way 
as it is in the West. China, for example, 
only began to 
implement a peer review system on 
a large scale in 1990, and the process 
is still developing. 
Peer review did exist in China as early 
as 1887, when the first English language 
Chinese medical 
journal was published. For about 100 years, 
though, this system existed primarily 
in English 
language journals. Probably because peer 
review in China is somewhat new 
compared with peer 
review in the West, Chinese peer 
review appears much simpler than 
western versions. In China, 
peer review mainly consists of closed 
review systems (those where reviewer 
identities are hidden 
but author identities are not). 
u Unlike in the West, debate over the 
most ethical type of peer 
review does not appear common in 
China. 
Authorship is another issue which seems far 
less developed in countries like China and 
Russia than in the West. Although authorship 
is a complex issue with several subcategories 
in 
the West, it is far simpler in China, where 
statements on authorship issues mainly consist 
of 
copyright regulations. The idea of intellectual property 
rights has apparently been developing in 
China mainly since 1995 and has not yet become 
as complex as authorship in the West. 
' 
Copyright laws discuss authorship 
qualification and coauthorship, but do not 
acknowledge other 
authorship issues. 
' In Russia, while scientists who work on 
international teams and/or publish 
papers in English language journals seem to view 
authorship the way it is viewed in western 
nations, authorship appears to be used outside 
of strictly international circles simply to refer to 
the designated author of a manuscript. 
' Although intellectual property rights are 
"a cornerstone 
of the Russian program, 
" authorship issues do not appear to be of concern. 
Other issues that are of concern in the West appear 
to be ignored in some nonwestern 
nations. Duplicate/redundant publication is 
one such issue. Although duplicate/redundant 
publication seems to be rampant in India, journals and 
the government both appear unwilling to 
address this problem. 
" '" In Turkey, some English language journals require 
authors to submit 
statements that no duplicate publication has 
occurred, " but non-English journals appear to have 
no such requirements, and government 
regulations seem to ignore the issue of 
duplicate/redundant publication altogether. 
' Table 1 lists some of the differences in views on 
peer review, authorship, and duplicate/redundant 
publication among various countries. 
The Impossibility of Standardization 
In the West alone, there is much variation 
in ethical standards in scientific publication 
among scientific fields and among 
nations. Constructing a standard code of ethical 
practice for 
these nations alone would be difficult, if not 
impossible, simply because there do not appear 
to 
be commonly accepted views and practices 
in relation to any ethical issues. A common 
code 
might be helpful to a few scientists, but 
to scientists in developing countries, 
such a code would 
be confusing and mi@t contain much information 
that would rarely be relevant. Scientists 
in 
developing countries are unlikely to need 
guidelines on issues not yet pertinent in their 
country, 
such as ghost authorship, open peer review 
systems, or the need to disclose past 
consultancy. 
Without international consensus, an 
international code would need to remain vague 
enough that 
it could include the accepted methods of handling 
scientific publication issues in all countries. 
Scientists in western industrialized nations 
would likely find an internationally 
standardized code 
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Table 1 
Exam les of International Differences 
issues 
Nations 
Western 
industrialized 
nations 
China 
India 
Turkey 
Peer review 
Crucial 
democratization of 
science; debate over 
most ethical and 
practical form. 
Uses primarily closed 
review; has only 
implemented peer 
review on a large 
scale in the last 15 
years. 
Appears to be similar 
to western nations. 
Appears similar to 
western nations. 
Authorship 
Complex group of 
issues including 
authorship credit, order 
of authors, group 
authorship, and 
honorary/ghost 
authorshi . 
Copyright law covers 
authorship credit and 
group authorship, but 
authorship is otherwise 
not a major issue. 
Appears to be similar to 
western nations. 
Addressed mainly in 
English language 
journals government 
uidelines va ue. 
Duplicate/redundant 
ublication 
A problem because it 
wastes valuable 
journalspace; most 
journals prohibit this 
except in cases where 
the two audiences do 
not overla . 
Unknown; not 
covered in 
government 
regulations but 
English language 
journals appear to 
have acknowledged 
the issue. 
Although apparently 
common, not 
identified as an issue 
by government or 
'oumals in India. 
Apparently addressed 
only in English 
lan ua e 'ournals. 
Russia 
Unknown; appears to 
be no documentation 
of peer review 
outside of English 
language journals or 
research conducted 
by international 
teams. 
Appears to refer only to 
authorship credit 
outside of Enghsh 
language journals or 
research conducted by 
international teams, 
which appear to share 
western values. 
Appears similar to 
western nations. 
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too vague to be of use, as it could not be as 
inclusive as guidelines previously developed 
in their 
own country. A standard ethical code 
seems infeasible because of the previously 
noted factors 
such as the apparent lack of consensus on 
issues and the nature of ethics. Although complex, 
the 
current system in which ethical practices 
in scientific publishing are monitored by 
journals, 
scientific organizations, and the government 
may be the best system, 
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CHAPTER VI 
PERSPECTIVES FROM THE INTERVIEWS 
To gain insight into the views 
researchers from various countries and 
fields have about 
ethics in scientific publishing, a 
questionnaire (Appendix C) was sent to 26 
researchers with 
experience as editors, authors, and peer 
reviewers. Background information 
on each subject was 
obtained, including current professional 
position, experience in scientific 
publication, and the 
number of years the individual had been 
working in his or her field. 
The researchers were then asked 
questions in two subject areas: their views on the 
multiple sets of standards and guidelines 
in scientific publication ethics and 
on the ethical 
climate in scientific publishing. The 
questions on the first subject area asked how 
familiar 
respondents were with applicable 
guidelines; how many sets they 
believed that they were 
expected to follow; how to handle a 
conflict between two sets of guidelines; how 
useful a single, 
standard ethical code would be; 
whether there were any legal guidelines 
that applied to scientific 
publication in their country; what 
penalties for noncompliance with 
these guidelines were; and 
how rigorously these guidelines 
were enforced. Questions about the ethical 
climate in scientific 
publishing asked whether the 
current climate was positive or negative, 
whether that climate had 
changed over time, and if so, how. 
Most of the questions were open ended. 
Thirteen responses were received. 
Three respondents were from Great 
Britain, three 
were from the continental United 
States, two were from Canada, and 
there was one respondent 
each from Austria, Germany, Japan, 
New Zealand, and Puerto Rico. 
Respondents' scientific 
fields were biology, biomedical 
science, computer science, geology, 
nuclear policy, psychology, 
sociology, science ethics, and zoology. 
Years of experience ranged from 12 to 
more than 40. 
Dealing with Multiple Standards 
and Guidelines 
Respondents were asked a series of questions 
to help determine how effective 
the almost 
innumerable sets of standards and guidelines 
in scientific publication ethics 
are at promoting 
ethical practices. First, they were 
asked about their familiarity with 
applicable ethical guidelines 
for publications in their flelds. 
Choices were "unaware, 
" 
"somewhat familiar, 
" 
"very familiar, " 
and "1 wrote them, 
" Ten respondents chose "somewhat 
familiar, " two chose "very familiar, 
" 
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and one respondent chose both "very 
familiar" and "I wrote them. " The respondents who 
were 
most familiar with ethical guidelines 
were from biomedical backgrounds. 
Asked how many sets 
of guidelines they believed they were expected 
to follow, answers ranged from four or 
five to 
"many. " The question of how to handle a conflict 
between different sets of guidelines produced 
more varied responses. Eleven respondents 
said that this question was not relevant. 
Some stated 
that it seemed unlikely that guidelines 
in similar fields would differ significantly, 
others said that 
the only difference between guidelines in 
similar fields was in the stringency of guidelines, 
and 
five said that they had never experienced 
any conflict. In cases where guidelines 
differed only in 
stringency, or one set of guidelines did not include 
something that another included, respondents 
said that the stricter guidelines should 
be followed. One respondent said that if a 
conflict arose, 
scientists should act in the manner that 
would be of greatest social benefit because this 
was of 
greater importance than any guidelines. 
The final respondent made the ambiguous 
statement that 
the most applicable of the guidelines should be 
followed, 
The next question asked whether a single, 
standard ethical code for scientific publication 
would be more or less useful than the many 
codes currently available. Ten respondents 
said that 
it would make no difference to them, 
one said that it would be less useful 
because it would be 
too open ended, one said that creating a 
single, standard ethical code would be 
impossible, and 
one respondent stated that it would be 
less useful "because it could not address 
some of the very 
specific areas of importance in some areas 
without being too detailed for practical 
use. 
" 
When asked about legal guidelines in their 
countries, eight respondents (from Austria, 
Canada, Great Britain, New Zealand, 
Puerto Rico, and the United States) said they were 
not 
aware of any. The other five respondents (from 
Germany, Great Britain, Japan, and the 
United 
States) referred to copyright laws, intellectual property 
laws, and libel. No one mentioned laws, 
regulations, or even government 
recommendations that deal with the ethical 
issues examined in 
the previous chapters. ln addition, no 
one appeared to have any clear idea 
about penalties or 
enforcement; answers to the question about 
this subject were "variable, 
" 
"unknown, " and "it 
depends. " 
It appears that respondents in biomedical 
fields were most familiar with guidelines 
on 
publication ethics. While several respondents 
were aware that many sets of guidelines exist, 
overall the responses suggest that the 
guidelines were not important to most 
respondents. One 
respondent stated that there are many types 
of guidelines, some that are advisory and 
others that 
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are disciplinary; be said that the disciplinary 
codes were the important ones. This suggests 
that 
some researchers believe following ethical 
guidelines is necessary only to avoid punishment. 
In general, it seems thai the respondents 
did not think that ethical issues in scientific 
publication were a major concern. Although many of the 
responses were lengthy, no onc 
mentioned any concrete examples of ethical 
misconduct. Several respondents gave vague 
answers to questions, suggesting that 
scientific publishing ethics was not a subject of concern. 
Five respondents stated that they had never 
experienced any problems with ethical infractions, 
and one said that the few problems he 
had seen had been minor and quickly 
resolved. This 
implies either that the group surveyed has 
encountered a lower rate of ethical problems than the 
g to 20'i'o reported in the literature (see Chapter 4), that 
problems with ethical misconduct in 
publishing are less widespread than the 
literature suggests, or that respondents 
encountered 
ethical problems but did not perceive them 
as such. 
It is somewhat surprising that no one 
seemed aware of any government agency 
guidelines on ethical practices in scientific 
publication. Because respondents showed little 
knowledge of enforcement, it seems that enforcement 
must not be common. 
The Ethical Climate in Scientific Publishing 
When asked about the current climate in 
scientific publishing and whether this climate 
had changed during their careers, eight 
respondents said that the current climate 
was mostly 
positive but that there are a few problems, 
mainly related to authorship. Another 
respondent also 
said that the current ethical climate was 
boih positive and negative. She also said 
that in the 
current ethical climate some researchers 
tend to think the worst of their fellows, labeling 
minor 
mistakes as misconduct. Four respondents 
did not identify the current ethical climate 
in 
scientific publishing as positive or negative. 
Instead, two respondents listed a few ethical 
problems such as authorship and two 
others asked questions of their own, such as: 
"What makes 
an environment positive or negative?" 
"Does this mean publication is encouraged?*' 
Respondents posed several explanations 
for ihe changes they had perceived in the 
ethical 
climate, Six respondents said that the ethical 
climate in scientific publishing has improved 
over 
time because of increased awareness of ethical 
issues. Six other respondents mentioned 
similar 
explanations for changes they perceived and also 
mentioned apparent increases in the rate of 
occurrence of misconduct; however, these respondents 
gave no indication of whether the ethical 
climate had improved or deteriorated over 
time. The remaining respondent stated 
thai ethical 
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debates concerning scientific publication have 
been increasingly influenced by nonscientific 
factors, such as legal proceedings and the agendas 
of religious groups. 
Although some researchers find the current 
ethical climate in scientific publishing to be 
mostly positive, it seems that others perceive 
problems. One respondent suggested that the 
increasing focus on ethics has created this perception by 
making researchers suspicious of each 
other. She also stated that the existence of more 
regulations prevents free discussion of issues. 
This may be true, although it seems somewhat 
unlikely considering that debate over ethical 
issues has increased in the literature over the 
past decades (see Chapter 4). 
Closing Comments 
Overall, this survey appears to show that most 
researchers do not find the many 
available ethical guidelines for scientific publishing 
to be particularly useful. Although issues of 
peer review, authorship, conflict of interest, 
publication bias, and duplicate/redundant 
publication have become prominent in the 
literature in the last 15 years, it seems that 
researchers 
are still largely unaware of the issues or their 
significance. lt appears that greater education 
for 
researchers outside of the field of publication ethics may 
be needed in addition to more empirical 
studies to decrease the occurrence of ethical infractions 
in scientific publications. 
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CHAPTER VII 
SUMMARY AND CONCLUSIONS 
Scientific publication is vital to the dissemination of knowledge 
and the growth of 
science, and is also an area full of ethical issues. Although 
many studies of these issues have 
been conducted, this is one of the first studies to consider 
ethical issues in scientific publication 
in historical and international perspectives. 
Understanding thc historical development and 
international differences in the main ethical issues 
in publishing is an essential step in providing 
insight into future ethical developments in 
scientific publication. 
In this study, I performed a comprehensive 
review of Internet sites and books and 
articles published after 1970. I also sent surveys to 
26 researchers with experience as editors, 
authors, and peer reviewers to help fill gaps 
in the literature. 
ln the last 25 years, scientific publication 
ethics has become its own field of research, 
with hundreds of articles published annually. Although 
there are many topics in publication 
ethics, five appear the most oflen: peer review, 
authorship, conflict of interest, publication bias, 
and duplicate/redundant publication. 
Ethical issues are those issues that involve 
choosing between two or more competing 
values. It is not surprising, then, that each of the 
five main groups of ethical issues is the subject 
of much debate. Peer review debate focuses on which type 
of peer review is both most ethical 
and most practical. Debates over authorship 
issues cover authorship credit, order of authors, and 
group authorship. The conflict of interest 
debate is essentially about when conflicts should 
be 
disclosed. The existence and extent of publication 
bias are frequently debated, as is the rate of 
occurrence of duplicate/redundant publication. 
By tracing the development of issues in 
scientific publication ethics, an understanding 
of 
ethical progress thus far can be gained, and the 
path to future progress may be illuminated. 
Although several of the issues in publication ethics 
have existed since before the first scientific 
journal was published, these issues were rarely acknowledged 
in the literature until the latter part 
of the 20'" century. Not until afler World War Il, 
when scientists began to focus more on all 
aspects of ethical conduct, were long-time issues 
like peer review and authorship brought to 
the 
attention of the scientific community and the public 
at large. 
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At this time, ethical issues in scientific publication were addressed in a handful 
of 
opinion articles, mainly appearing in biomedical journals, presenting the authors' views on peer 
review, authorship, conflict of interest, publication bias, and duplicate/redundant publication. 
In the 1970s and early 1980s, researchers called for empirical studies to be conducted 
on these 
and other issues in publication ethics. In the last 20 years, much research has been 
conducted on 
these issues, and the scientiTic literature has expanded. 
As yet, there are no commonly accepted right or wrong ways of dealing with these 
issues. Among different fields and nations, these five groups of issues are handled in a variety 
of 
ways. Ethical codes and guidelines are available to help guide scientists in 
the direction of 
accepted conduct in their fields. Government agencies in some countries provide 
similar 
guidelines, although some are prescriptive rather than advisory. In general, 
the more limited 
political freedom is in a nation, the more prescriptive guidelines tend to be. Many 
of these 
guidelines are posted on the Internet and readily available to scientists. 
Based on responses to the questionnaire (Appendix C), scientists appear to be largely 
unaware of ethical issues in scientific publication. Few seemed aware that problems 
exist; in 
fact, two respondents said that they found the climate in scientific publication 
overly suspicious. 
However, the questionnaire was only sent to 26 researchers, and only 13 responses 
were 
received. Certainly this is not an adequate sample from which to draw 
accurate generalizations. 
Another survey, distributed on a much larger scale with questions that 
are more clearly 
explained, miPt show more exactly how effective articles and guidelines have been in 
increasing awareness of ethical issues. It might also give a better understanding of how 
widespread ethical problems in scientific publishing are. 
With easily accessible guidelines available and more and more articles on 
issues in 
publication ethics published each year, it seems reasonable that the rate 
of occurrence of ethical 
infractions should be decreasing. However, this does not appear to be the 
case. Despite 
increasing chances for scientists to become aware of ethical issues, recent studies 
that gave rates 
of occurrence of infractions in areas where such rates had been previously calculated 
show that 
ethical infractions occur at about the same rate as 25 years ago. The extremely 
limited survey 
data also appears to support this. (See Chapter VI. ) 
Scientists appear to be mostly unaware of ethical issues in publication. Continued 
lack 
of awareness may be because as the volume of articles published on publication ethics 
has 
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increased, so has the volume of articles in nearly every other scientific field. It may be too time 
consuming for researchers to read many articles outside of their own fields. 
As more ethical codes and guidelines have been created, finding the appropriate action 
in each situation may be more difficult. Many scientists appear to believe that there is little 
difference between sets of guidelines in similar fields; they may be using codes that do not 
include guidelines on all pertinent issues or that are out of date. Also, it seems likely that 
scientists turn to standards and guidelines only when they perceive a problem; however, 
problems may exist unnoticed. 
lt is also possible that occurrences of misconduct are not staying the same, but rather that 
misconduct is more likely to be noticed because of the increase in awareness of ethical issues. It 
seems that because greater discussion of ethical issues in scientific publishing has led to greater 
awareness, it has also led to increased scrutiny and possibly to a more suspicious environment. 
lf discussion of ethical issues in the literature continues to increase, perhaps misconduct will 
occur less and less as it grows more difficult not to be caught by well-informed peers. 
More research reports and other articles may not be enough to increase awareness of 
ethical problems in publication in the scientific community. Increased education, including more 
continuing education programs similar to some already in place, may also be needed. Publishing 
handbooks and making guidelines available does not appear to be enough, since many scientists 
seem largely indifferent to such publications. 
Ensuring that scientists are aware of ethical standards seems to be a task that journal 
editors and scientific professional societies have taken upon themselves. These groups have 
published many codes of ethical conduct. They have sponsored conferences and published 
articles discussing the current situation in publication ethics. But education stemming from these 
individuals and organizations does not appear to be adequate. 
Like proper research techniques, publication ethics may be best taught through 
mentoring, where young scientists have the opportunity to work one-on-one with more 
experienced researchers. The mentoring system already in place may need to be strengthened 
and reinforced. When mentors are alert to poor publication practices exhibited by students, 
the 
proper ethical solution can be explained and the student can develop awareness of ethical issues 
in scientific publishing. Some researchers already focus on publication with their students, but 
others spend less time on this subject. Students can leam by example when scientific publication 
is made a more formal part of the mentoring process. Working closely with an experienced 
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researcher, young scientists can leam to understand the importance of proper ethical practices in 
scientific publication. 
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Appendix C 
Interview Questionnaire 
Instructions: Please answer the following questions. You do not have to answer all of the 
questions if you are uncomfortable doing so. Thank you for your time. 
1. Background information: 
a. What is your name and current professional position? 
b. What experience have you had in scientific publishing (as an author, editor, referee, etc. )? 
c. How long have you been working in your current field? 
2. Many professional organizations in the scientific community have their own sets of 
guidelines for good publication practices. Journals also provide such guidelines. In addition, 
several other organizations such as the Committee on Publication Ethics provide still more 
guidelines. 
a. How familiar are you with applicable guidelines in your field? 
unaware 
somewhat familiar 
very familiar 
I wrote them 
b. How many sets of ethical guidelines do you believe you are expected to follow? For 
example, someone who is a member of two professional organizations and regularly submits 
his/her research to one of two journals might follow two sets of professional guidelines and two 
sets of journal guidelines. 
c. If you experienced a conflict between the guidelines set forth by your professional society and 
those recommended by a journal in which you wished to publish research (for example, 
regarding authorship or disclosure of a conflict of interest), how would you try to resolve the 
conflict? If you are a journal editor, how would you respond to a query from a potential author 
about such a conflict? 
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3. Would a single, standard ethical code for scientilic publication be more or less useful than the 
numerous sets of guidelines currently available? 
It would be more useful, and I think one should be developed. 
lt would be more useful, but I don't think it would be possible to develop one. 
It would not make any difference for me. 
It would be less useful because it would have to be so open ended. 
A single, standard ethical code is an impossibility. 
Other. 
Please explain your answer choice. 
4. Do you know of any legal guidelines that researchers in your country are required to observe 
in relation to the publication of research (or, if relevant, the publication of a scientific journal)' & 
Please do not include laws regarding conduct of research. 
If yes: 
a. What are the penalties for noncompliance? 
b. To your knowledge, how rigorously are these laws enforced? 
5. Do you think the current ethical climate with regard to scientific publishing is positive or 
negative? Why? 
6. Do you feel the ethical climate regarding the publication of scientific research has changed 
over the course of your career? If so, how? 
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Appendix D 
Selected Guidelines for SclentiTic Publication Ethics 
Excerpts from: Committee on Publication Ethics (COPE) 
Guidelines on Good Publication Practice 2002 
Available online at http: //www publicationethicxorg. uktcope2002/pdfl002I 
These guidelines are intended to be advisory rather than prescriptive, and to evolve over time. 
We hope that they will be disseminated widely, endorsed by editors, and refined by those who 
use them. 
3. Authorship 
Definition 
There is no universally agreed definition of authorship, although attempts have been made (see 
Appendix). As a minimum, authors should take responsibility for a particular section of the 
study. 
Action 
(I) The award of authorship should balance intellectual contributions to the conception, design, 
analysis and writing of the study against the collection of data and other routine work. lf there is 
no task that can reasonably be attributed to a particular individual, then that individual should not 
be credited with authorship. 
(2) To avoid disputes over attribution of academic credit, it is helpful to decide early on in the 
planning of a research project who will be credited as authors, as contributors, and who will be 
acknowledged. 
(3) lf professional writers employed by pharmaceutical companies, medical agencies, or other 
parties have written the paper, then their names should be included, and any conflicts of interest 
declared, 
(4) All authors must take public responsibility for the content of their paper. The 
multidisciplinary nature of much research can make this difficult, but this can be resolved by the 
disclosure of individual contributions. 
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(5) Careful reading of the target journal's "Advice to Authors" is advised, in the light of current 
uncertainties. 
(6) Authors should be vigilant about allowing their name to be used on a piece of work to add 
credibility to the content. 
4. Conflicts of interest 
Definition 
Conflicts of interest arise when authors, reviewers, or editors have interests that are not fully 
apparent and that may influence their judgments on what is published. They have been 
described as those which, when revealed later, would make a reasonable reader feel misled 
or deceived. They may be personal, commercial, political, academic, or financial. "Financial" 
interests may include employment, research funding, stock or share ownership, payment for 
lectures or travel, consultancies and company support for staff. 
Action 
(I) Such interests, where relevant, must be declared to editors by researchers, authors, and 
reviewers. 
(2) Editors should also disclose relevant conflicts of interest to their readers. If in doubt, disclose. 
(3) Editors should also consider disclosing to readers their own conflicts of interest and those of 
their teams, editorial boards, managers, and owners. 
(4) Sometimes conflicts of interest may be so extreme that publication will not be possible or 
people (for example, reviewers or editors) may have to be excluded from decisions on 
publication. 
5. Peer review 
Definition 
Peer reviewers are external experts chosen by editors to provide written opinions, with the aim of 
improving the study. Working methods vary from journal to journal, but some use open 
procedures in which the name of the reviewer is disclosed, together with the full or "edited" 
report. 
Action 
(I) Suggestions from authors as to who might act as reviewers are often useful, but there should 
be no obligation on editors to use those suggested. 
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(2) The duty of confidentiality in the assessment of a manuscript must be maintained by expert 
reviewers, and this extends to reviewers' colleagues who may be asked (with the editor' s 
permission) to give opinions on specific sections. 
(3) The submitted manuscript should not be retained or copied. 
(4) Reviewers and editors should not make any use of the data, arguments, or interpretations, 
unless they have the authors' permission. 
(5) Reviewers should provide speedy, accurate, courteous, unbiased and justifiable reports. 
(6) If reviewers suspect misconduct, they should write in confidence to the editor. 
(7) Journals should publish accurate descriptions of their peer review, selection, and appeals 
processes. 
(g) Journals should also provide regular audits of their acceptance rates and publication times. 
6. Redundant publication 
Definition 
Redundant publication occurs when two or more papers, without full cross reference, share the 
same hypothesis, data, discussion points, or conclusions. 
Action 
( I) Published studies do not need to be repeated unless further confirmation is required. 
(2) Previous publication of an abstract during the proceedings of meetings does not preclude 
subsequent submission for publication, but full disclosure should be made at the time of 
submission. 
(3) Re-publication of a paper in another language is acceptable, provided that there is full and 
prominent disclosure of its original source at the time of submission. 
(4) At the time of submission, authors should disclose details of related papers, even if in a 
different language, and similar papers in press. 
(5) All original studies should be peer reviewed before publication, taking into full account 
possible bias due to related or conflicting interests. 
(6) Editors must treat all submitted papers as confidential. 
(7) When a published paper is subsequently found to contain major flaws, editors must accept 
responsibility for correcting the record prominently and promptly. 
(g) Where misconduct is suspected, the editor must write to the authors first before contacting 
the head of the institution concerned. 
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(9) Editors should ensure that the instructions to Authors specify the need for authors to obtain 
informed consent from patients included in their research. 
Excerpts from: American Chemical Society 
Ethical Guidelines tu Publication of Chemical Research, January 2000. 
Available online at: http: //pubs. acs. org/instruct/ethic2000 pdf. 
Preface 
The American Chemical Society serves the chemistry profession and society at large in 
many ways, among them by publishing journals which present the results of scientific and 
engineering research. Every editor of a Society journal has the responsibility to establish and 
maintain guidelines for selecting and accepting papers submitted to that journal. In the main, 
these guidelines derive from the Society's definition of the scope of the journal and from the 
editor's perception of standards of quality for scientific work and its presentation. An essential 
feature of a profession is the acceptance by its members of a code that outlines desirable 
behavior and specifies obligations of members to each other and to the public. Such a code 
derives from a desire to maximize perceived benefits to society and to the profession as a whole 
and to limit actions that might serve the narrow selfinterests of individuals. The advancement of 
science requires the sharing of knowledge between individuals, even though doing so may 
sometimes entail foregoing some immediate personal advantage. With these thoughts in mind, 
the editors of journals published by the American Chemical Society now present a set of ethical 
guidelines for persons engaged in the publication of chemical research, specifically, for editors, 
authors, and manuscript reviewers. These guidelines are offered not in the sense that there is any 
immediate crisis in ethical behavior, but rather from a conviction that the observance of high 
ethical standards is so vital to the whole scientific enterprise that a definition of those standards 
should be brought to thc attention of all concerned. 
We believe that most of the guidelines now offered are already understood and 
subscribed to by the majority of experienced research chemists. They may, however, be of 
substantial help to those who are relatively new to research. Even well-established scientists may 
appreciate an opportunity to review matters so significant to the practice of science. 
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Guidelines 
A. Ethical Obligations of Editors of Scientific Journals 
l. An editor should give unbiased consideration to all manuscripts offered for publication, 
judging each on its merits without regard to race, religion, nationality, sex, seniority, or 
institutional affiliation of the author(s). An editor may, however, take into account relationships 
of a manuscript immediately under consideration to others previously or concurrently offered by 
the same author(s). 
2. An editor should consider manuscripts submitted for publication with all reasonable speed. 
3. The sole responsibility for acceptance or rejection of a manuscript rests with the editor. 
Responsible and prudent exercise of this duty normally requires that the editor seek advice from 
reviewers, chosen for their expertise and good judgment, as to the quality and reliability of 
manuscripts submitted for publication. However, manuscripts may be rejected without review if 
considered inappropriate for the journal 
4. The editor and members of the editor's staff should not disclose any information about a 
manuscript under consideration to anyone other than those from whom professional advice is 
sought. (However, an editor who solicits, or otherwise arranges beforehand, the submission of 
manuscripts may need to disclose to a prospective author the fact that a relevant manuscript by 
another author has been received or is in preparation. ) After a decision has been made about a 
manuscript, the editor and members of the editor's staff may disclose or publish manuscript titles 
and authors' names of papers that have been accepted for publication, but no more than that 
unless the author's permission has been obtained. 
5. An editor should respect the intellectual independence of authors. 
6. Editorial responsibility and authority for any manuscript authored by an editor and submitted 
to the editor's journal should be delegated to some other qualified person, such as another editor 
of that journal or a member of its Editorial Advisory Board. Editorial consideration of the 
manuscript in any way or form by the author-editor would constitute a conflict of interest, and is 
therefore improper. 
7. Unpublished information, arguments, or interpretations disclosed in a submitted manuscript 
should not be used in an editor's own research except with the consent of the author. However, if 
such information indicates that some of the editor's own research is unlikely to be profitable, the 
editor could ethically discontinue the work. When a manuscript is so closely related to the 
current or past research of an editor as to create a conflict of interest, the editor should arrange 
for some other qualified person to take editorial responsibility for that manuscript. In some cases, 
it may be appropriate to tell an author about the editor's research and plans in that area. 
g. If an editor is presented with convincing evidence that the main substance or conclusions of a 
report published in an editor' s journal are erroneous, the editor should facilitate publication of an 
appropriate report pointing out the error and, if possible, correcting it. The report may be written 
by the person who discovered the error or by an original author. 
9. An author may request that the editor not use certain reviewers in consideration of a 
manuscript. However, the editor may decide to use one or more of these reviewers, if the editor 
feels their opinions are important in the fair consideration of a manuscript. This might be the 
case, for example, when a manuscript seriously disagrees with the previous work of a potential 
reviewer. 
B. Ethical Obligations of Authors 
l. An author's central obligation is to present an accurate account of the research performed as 
well as an objective discussion of its significance. 
2. An author should recognize that journal space is a precious resource created at considerable 
cost. An author therefore has an obligation to use it wisely and economically. 
3. A primary research report should contain sufficient detail and reference to public sources of 
information to permit the author's peers to repeat the work. When requested, the authors should 
make a reasonable effort to provide samples of unusual materials unavailable elsewhere, such as 
clones, microorganism strains, antibodies, etc. , to other researchers, with appropriate material 
transfer agreements to restrict the field of use of the materials so as to protect the legitimate 
interests of the authors. 
4. An author should cite those publications that have been influential in determining the nature of 
the reported work and that will guide the reader quickly to the earlier work that is essential for 
understanding the present investigation. Except in a review, citation of work that will not be 
referred to in the reported research should be minimized. An author is obligated to perform a 
literature search to find, and then cite, the original publications that describe closely related 
work. For critical materials used in the work, proper citation to sources should also be made 
when these were supplied by a nonauthor. 
5. Any unusual hazards inherent in the chemicals, equipment, or procedures used in an 
investigation should be clearly identified in a manuscript reporting the work. 
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6. Fragmentation of research reports should be avoided. A scientist who has done extensive work 
on a system or group of related systems should organize publication so that each report gives a 
wellrounded account of a particular aspect of the general study. Fragmentation consumes journal 
space excessively and unduly complicates literature searches. The convenience of readers is 
served if reports on related studies are published in the same journal, or in a small number of 
journals. 
7. In submitting a manuscript for publication, an author should inform the editor of related 
manuscripts that the author has under editorial consideration or in press. Copies of those 
manuscripts should be supplied to the editor, and the relationships of such manuscripts to the one 
submitted should be indicated. 
8. It is improper for an author to submit manuscripts describing essentially the same research to 
more than one journal of primary publication, unless it is a resubmission of a manuscript rejected 
for or withdrawn from publication. It is generally permissible to submit a manuscript for a full 
paper expanding on a previously published brief preliminary account (a "communication" or 
"letter" ) of the same work. However, at the time of submission, the editor should be made aware 
of the earlier communication, and the preliminary communication should be cited in the 
manuscript. 
9. An author should identify the source of all information quoted or offered, except that which is 
common knowledge. Information obtained privately, as in conversation, correspondence, or 
discussion with third parties, should not be used or reported in the author's work without explicit 
permission from the investigator with whom the information originated. 
Information obtained in the course of confidential services, such as refereeing manuscripts or 
grant applications, should be treated similarly. 
10. An experimental or theoretical study may sometimes justify criticism, even severe criticism, 
of the work of another scientist. When appropriate, such criticism may be offered in published 
papers. However, in no case is personal criticism considered to be appropriate. 
11. The co-authors of a paper shouM be all those persons who have made significant scientific 
contributions to the work reported and who share responsibility and accountability for the 
results, Other contributions should be indicated in a footnote or an "Acknowledgments" section. 
An administrative relationship to the investigation does not of itself qualify a person for co- 
authorship (but occasionally it may be appropriate to acknowledge major administrative 
assistance). Deceased persons who meet the criterion for inclusion as co-authors should be so 
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included, with a footnote reporting date of death. No fictitious name should be listed as an author 
or coauthor. 
The author who submits a manuscript for publication accepts ihe responsibility of having 
included as co-authors all persons appropriate and none inappropriate. The submitting author 
should have sent each living co-author a draft copy of the manuscript and have obtained the co- 
author's assent to co-authorship of it. 
12. The authors should reveal to the editor any potential conflict of interest, e. g. , a consulting or 
financial interest in a company, that might be affected by publication of the results contained in a 
manuscript. The authors should ensure that no contractual relations or proprietary considerations 
exist that would affect the publication of information in a submitted manuscript. 
C. Ethical Obligations of Reviewers of Manuscripts 
I. Inasmuch as the reviewing of manuscripts is an essential step in the publication process, and 
therefore in the operation of the scientific method, every scientist has an obligation to do a fair 
share of reviewing. 
2. A chosen reviewer who feels inadequately qualified to judge the research reported in a 
manuscript should return it promptly to the editor. 
3. A reviewer (or referee) of a manuscript should judge objectively the quality of the manuscript, 
of its experimental and theoretical work, of its interpretations and its exposition, with due regard 
to the maintenance of high scientific and literary standards. A reviewer should respect the 
intellectual independence of the authors. 
4. A reviewer should be sensitive to the appearance of a conflict of interest when the manuscript 
under review is closely related to the reviewer's work in progress or published. If in doubt, the 
reviewer should return the manuscript promptly without review, advising the editor of the 
conflict of interest or bias. Alternatively, the reviewer may wish to furnish a signed review 
stating the reviewer's interest in the work, with the understanding that it may, at the editor' s 
discretion, be transmitted to the author. 
5. A reviewer should not evaluate a manuscript authored or co-authored by a person with whom 
the reviewer has a personal or professional connection if the relationship would bias judgment of 
the manuscript. 
6. A reviewer should treat a manuscript sent for review as a confidential document. It should 
neither be shown to nor discussed with others except, in special cases, to persons from whom 
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specific advice may be sought; in that event, the identities of those consulted should be disclosed 
to the editor. 
7. Reviewers should explain and support their judgments adequately so that editors and authors 
may understand the basis of their comments. Any statement that an observation, derivation, or 
argument had been previously reported should be accompanied by the relevant citation. 
Unsupported assertions by reviewers (or by authors in rebuttal) are of little value and should be 
avoided. 
8. A reviewer should be alert to failure of authors to cite relevant work by other scientists, 
bearing in mind that complaints that the reviewer's own research was insufliciently cited may 
seem self-serving. A reviewer should call to the editor's attention any substantial similarity 
between the manuscript under consideration and any published paper or any manuscript 
submitted concurrently to another journal. 
9. A reviewer should act promptly, submitting a report in a timely manner. Should a reviewer 
receive a manuscript at a time when circumstances preclude prompt attention to it, the 
unreviewed manuscript should be returned immediately to the editor. Alternatively, the reviewer 
might notify the editor of probable delays and propose a revised review date. 
10. Reviewers should not use or disclose unpublished information, arguments, or interpretations 
contained in a manuscript under consideration, except with the consent of the author. If this 
information indicates that some of the reviewer's work is unlikely to be profitable, the reviewer, 
however, could ethically discontinue the work. In some cases, it may be appropriate for the 
reviewer to write the author, with copy to the editor, about the reviewer's research and plans in 
that area. 
11. The review of a submitted manuscript may sometimes justify criticism, even severe criticism, 
from a reviewer. When appropriate, such criticism may be offered in published papers. However, 
in no case is personal criticism of the author considered to be appropriate. 
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Excerpts from: International Committee of Medical Journal Editors 
Uniform Requirements for Manuscripts Submitted to Biomedical Journals, January 1997. 
Available online ai: wvvw. icmj e. org, 
Redundant or Duplicate Publication 
Redundant or duplicate publication is publication of a paper that overlaps substantially 
with one already published. 
Readers of primary source periodicals deserve to be able to trust that what they are 
reading is original unless there is a clear statement that the article is being republished by the 
choice of the author and editor. The bases of this position are international copyright laws, 
ethical conduct, and cost-effective use of resources. 
Most journals do not wish to receive papers on work that has already been reported in 
large part in a published article or is contained in another paper that has been submitted or 
accepted for publication elsewhere, in print or in electronic media. This policy does not preclude 
the journal considering a paper that has been rejected by another journal, or a complete rcport 
that follows publication of a preliminary report, such as an abstract or poster displayed for 
colleagues at a professional meeting. Nor does it prevent journals considering a paper that has 
been presented at a scientific meeting but not published in full or that is being considered for 
publication in a proceedings or similar format. Press reports of scheduled meetings will not 
usually be regarded as breaches of this rule, but such reports should not be amplified by 
additional data or copies of tables and illustrations. 
When submitting a paper, the author should always make a full statement to the editor 
about all submissions and previous reports that might be regarded as redundant or duplicate 
publication of the same or very similar work. The author should alert the editor if the work 
includes subjects about which a previous report has been published. Any such work should be 
referred to and referenced in the new paper. Copies of such material should be included with the 
submitted paper to help the editor decide how to handle the matter. 
If redundant or duplicate publication is attempted or occurs without such notification, 
authors should expect editorial action to be taken. At the least, prompt rejection of the submitted 
manuscript should be expected. If the editor was not aware of the violations and the article has 
already been published, then a notice of redundant or duplicate publication will probably be 
published with or without the author's explanation or approval. 
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Preliminary reporting to public media, governmental agencies, or manufacturers, of 
scientific information described in a paper or a letter to the editor that has been accepted but not 
yet published violates the policies of many journals. Such reporting may be warranted when the 
paper or letter describes major therapeutic advances or public health hazards such as serious 
adverse etTects of drugs, vaccines, other biological products, or medicinal devices, or reportable 
diseases. This reporting should not jeopardize publication, but should be discussed with and 
agreed upon by the editor in advance. 
Authorship 
All persons designated as authors should qualify for authorship, and all those who 
qualify should be listed. Each author should have participated sufflciently in the work to take 
public responsibility for appropriate portions of the content. One or more authors should take 
responsibility for the integrity of the work as a whole, from inception to published article. 
Authorship credit should be based only on I) substantial contributions to conception and 
design, or acquisition of data, or analysis and interpretation of data; 2) drafling the article or 
revising it critically for important intellectual content; and 3) final approval of the version to bc 
published. Conditions I, 2, and 3 must all be met. Acquisition of funding, the collection of data, 
or general supervision of the research group, by themselves, do not justify authorship. 
Authors should provide a description of what each contributed, and editors should 
publish that information. All others who contributed to the work who are not authors should be 
named in the Acknowledgments, and what they did should be described. 
Increasingly, authorship of multicenter trials is attributed to a group. All members of the 
group who are named as authors should fully meet the above criteria for authorship. Group 
members who do not meet these criteria should be listed, with their permission, in the 
Acknowledgments or in an appendix. 
The order of authorship on the byline should be a joint decision of the coauthors. 
Authors should be prepared to explain the order in which authors are listed. 
Conflict of Interest 
Conflict of interest for a given manuscript exists when a participant in the peer review 
and publication process-author, reviewer, and editor-has ties to activities that could 
inappropriately influence his or her judgment, whether or not judgment is in fact affected. 
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Financial relationships with industry (for example, through employment, consultancies, stock 
ownership, honoraria, expert testimony), either directly or through immediate family, are usually 
considered to be the most important conflicts of interest. However, conflicts can occur for other 
reasons, such as personal relationships, academic competition, and intellectual passion. 
Public trust in the peer review process and the credibility of published articles depend in 
part on how well conflict of interest is handled during writing, peer review, and editorial 
decision making. Bias can often be identified and eliminated by careful attention to the scientific 
methods and conclusions of the work, Financial relationships and their eflects are less easily 
detected than other conflicts of interest. Participants in peer review and publication should 
disclose their conflicting interests, and the informa)ion should be made available so that others 
can judge their effects for themselves. Because readers may be less able to detect bias in review 
articles and editorials than in reports of original research, some journals do not accept reviews 
and editorials from authors with a conflict of interest. 
Excerpts from: Council of Science Editors 
Editorial Policy Statements Approved by the CSE Board of Directors. 
Available online ai: brtpr//w w w. co unci lsci ence editors or g/services Edi rori al palici es shim l. 
Conflicts of Interest and the Peer Review Process 
Objective 
To offer guidelines useful to biomedical journals as they develop policies and procedures 
relating to conflict of interest in peer review. 
Definition 
A widely used American dictionary (Webster's 9th New Collegiate Dictionary) defines 
conflict of interest as a "conflict between the private interests and the official responsibilities of a 
person in a position of trust. " In scientific publishing, the author of a manuscript, the reviewer, 
and the editor are all persons "in a position of trust. " 
Conflicts of interest in the publishing can be defined as sets of conditions in which an 
author, editor, or reviewer holds conflicting or competing interests that could result in bias or 
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improper decisions. The conflicts of interest may only be potential conflicts of interest or only 
perceived, and not necessarily even potential, conflicts. 
The determination of whether a conflict of interest ~actuafl exists can be extraordinarily 
difficult and oflen contentious. Recognizing the potential for conflicts of interest is usually 
easier; they are common and it is not their existence, but rather their potential to cause bias and 
failure to acknowledge or recognize conflicts, that causes concern. Such failure, which reflects 
an insensitivity to the potential for conflict of interest, is troubling, whether it is observed in an 
author, a reviewer, or an editor. 
Ideally, authors are completely objective in presenting their findings, and editors and 
reviewers are entirely objective in evaluating them. These processes are all prey to biases. 
Personal, political, financial, academic, or religious considerations can affect objectivity in 
innumerable ways. The challenge for authors, editors, and reviewers is to recognize the potential 
for biases arising from conflicts of interest and to respond appropriately. 
Financial Conflicts 
The most evident type of potential conflict of financial interest is the situation in which a 
commercial product is under study and the author, reviewer, or editor stands to benefit 
financially if the assessment of the product goes one way or another. For example, an author 
reporting investigation of a specific product, at the same time he or she holds equity positions or 
stock options in the company that makes the products, clearly has the potential to realize direct 
financial gain if the assessment is favorable. A researcher in the employ of a for-profit enterprise 
has a slightly less direct relationship to product-related research, but still can reasonably expect 
to benefit financially if a product does well. In these examples, an individual's "private interests" 
(i. e. , his or her financial interests) are potentially in conflict with his or her "official 
responsibilities" (i. e. , the responsibility of a scientist to seek the truth). 
The situation in which an investigator studies a product of a for-profit enterprise from 
which the investigator has received monies previously (e. g. , as a consultant or in the form of an 
honorarium or speaking fee) is slightly different. There is now no direct relationship between the 
evaluation and any personal gain the investigator may anticipate. Nevertheless, the existence of 
payments even in the past could conceivably influence research and must therefore be regarded 
as having thc potential to present conflicting interest. 
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The examples given above involve authors reporting the results of their research, non- 
research articles, reviews, and opinion pieces, but they could just as well involve reviewers 
evaluating a manuscript or editors deciding whether or not to accept a manuscript. There are 
some subtle differences among authors, reviewers, and editors with respect to conflict of 
financial interest, but the basic principles apply to all. 
Some journals refuse to consider manuscripts describing research involving a 
commercial product when the research was supported financially by a commercial organization 
involved in the manufacture or sale of the product. A few journals will not permit editorials or 
review articles to be authored by individuals with potential conflicts of financial interest, feeling 
that these pieces rely especially heavily on interpretation and judgment, and thereby make 
conflict of interest and the potential for bias especially problematic. 
Non-Financial Conflicts 
Many considerations — intellectual, political, academic, and religious, to mention just a 
few — can represent "private interests. " The challenge for authors, reviewers, and editors is to 
recognize the potential for these types of contlicts as well as those involving finances, and 
respond appropriately. Complete objectivity is not often possible, but fairness and even- 
handedness can reasonably be expected. For example, a reviewer strongly opposed to abortion, 
on religious or other moral grounds, might have diBiculty evaluating a manuscript describing the 
use of fetal tissue in research in an objective matter. Or an editor who is also chair of a 
department might have difficulty in reaching objective decisions about manuscripts submitted by 
his or her faculty because the editor has a "private interest" as a chair in helping the academic 
advancement of his faculty. 
Disclosure 
The key to recognizing and dealing with conflicts of interest - financial or non-financial 
- is disclosure: disclosure to the editor when a manuscript is submitted, and disclosure to the 
reader when a paper is published. The former provides a means for the manuscript to be 
evaluated by the editor with full knowledge of all its circumstances, and the latter assures that 
the reader will have sufficient information to interpret the work appropriately. 
Disclosure of potential financial conflicts of interest is meant to maintain the integrity of 
professional judgment and to maintain the public's confidence in professional judgment. A 
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disclosure does not infer that scientists are unduly influenced by financial gain. Rather, 
disclosure in such cases gives readers the information to allow them to make an informed 
decision because it is oflen diflicult to determine when research has been inappropriately 
influenced by financial gain. Informing readers is thc responsibility of the journal. Some, 
however, would argue that mandatory financial disclosure actually does not allow a manuscript 
to be judged solely on its merits. They believe that such disclosure is based on the faulty 
assumption that only financial considerations influence authors and that all authors are 
influenced. They further believe that such disclosure unfairly prejudices the reader against the 
author. See Rothman J. J. Conflict of Interest: the New McCarthyism in Science. JAMA 1993; 
269:2782-2784. 
Authors 
Many journals require that financial support of the work reported be identified with the 
submitted manuscript. Some examples, taken from the "Information for Authors" section of 
different journals follow: The checklist for submission to Science includes an item requiring 
inclusion of "any information about the authors' professional or financial al'filiations that may be 
perceived to have biased the presentation. " The Journal of the American Medical Association 
(JAMA) requires all authors to sign a statement disclosing "any affiliations with or financial 
involvement in any organization or entity with a direct financial interest in the subject matter or 
material discussed in the manuscript (e. g. , employment, consultancies, stock ownership, 
honoraria, expert testimony, current or pending patents. )" Gbslerrics and Gynecology uses 
similar wording and a time limit of three years is specified. Most journal policies ask authors to 
disclose their relevant financial interests when they submit their manuscripts. It is then the 
editor's responsibility to interpret this information and, if the paper is ultimately accepted, decide 
how (if at all) it is to be relayed to the reader. 
How should authors' disclosure of financial interests be handled during the peer review 
process? Journals seem to have differing policies on this point. Some make the information 
about financial disclosure available to reviewers and ask them to evaluate this, along with the 
scientific merit of the paper. The reviewers' opinion about the authors' financial interest may then 
weigh heavily in thc editor's decision and may result in a form of publication bias. Other journals 
keep as recommended by ICMIE (International Committee of Medical Journal Editors) such 
information confidential during the review process, and have it considered by the editor (perhaps 
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with outside evaluation on this point as well) only afler scientific merit is assessed. This latter 
approach has the advantage of dividing the question into clearly identifiable portions. 
Readers have the right to know any potential conflicts of interest. The considerations 
that interest journals the most are financial, which are usually the easiest to disclose. However, 
financial conflicts may not be easily detected without disclosure. Financial conflicts include 
salary, consulting fees and honoraria, stock or equity interests, and intellectual property rights 
(patents, royalties, and copyrights). Most journals require authors to declare any potential 
financial conflicts of interest they may have with the subject matter of their manuscripts. Some 
journals ask authors to disclose any financial interests they may have with any entity that could 
affect their work. 
The authors are responsible for declaring these potential conflicts of interests. Journals 
don't research possible conflicts of interest and are not expected to "police" authors. Flowever, 
journal editors must be alert to the possibility of conflicts of interest because the authors may not 
declare them. An author's failure to declare a financial interest conflicts with the reader' s 
entitlement to know this potential source of bias. Such information can help readers decide 
whether a particular sponsorship unduly influenced the investigator and whether the research 
findings are different than what they would otherwise have been. 
Examples of disclosure statements 
77te Journal of the American Medical A. ssociarion requires financial disclosure, in 
"Authorship criteria and responsibility, financial disclosure, assignment of copyright, and 
acknowledgement:" 
"Financial disclosure - I certify that any affiliations with or financial involvement in any 
organization or entity with a direct financial interest in the subject matter or materials discussed 
in the manuscript (e. g. , employment, consuhancies, stock ownership, honoraria, expert 
testimony) are disclosed below. Any financial project support of this research is identified in an 
acknowledgment in the manuscript. " 
Obstetrics and Gynecology requires each author to sign an agreement form that must 
accompany the manuscript submission with a section on financial disclosure: "l aflirm that 1 
have no financial affiliation (e. g. , employment, stock holdings, consultantships, or honoraria) 
within the last 3 years with any organization with direct financial interest in the subject or 
materials discussed in this manuscript, except as disclosed in an attachment. 
" 
79 
Science includes on its checklist for submission: "Also include with your 
manuscript: . any information about the authors' professional and financial affiliations that may 
be perceived to have biased the presentation. " 
Some journals (e. g. , thew England Journal of Medicine and Obstetrics and Gynecology) 
do not allow any financial conflict of interest for authors who write editorials or review articles, 
because analysis pieces rely heavily on interpretation and judgment. It is considered diAicult for 
readers to discern conflicts of interest in opinion pieces. 
At least one journal (Obstetrics and Gynecology) discloses financial matters in a "call- 
out" box, which is displayed on the front page of the published manuscript. When the editor feels 
that financial conflicts should be disclosed, he or she advises the corresponding author and 
indicates how the "financial disclosure" statement should be worded. This situation may occur if 
any of the authors have financial connections to a particular product or company and the article 
could be interpreted as favorable to that product or company. Acceptance of the manuscript is 
contingent upon the author's accepting the disclosure. 
Reviewers 
Conflicts of interest regarding reviewers concern not only financial issues, but also 
rivalry, academic scientific and technologic competition, and philosophical values and beliefs. 
Reviewers, when asked to review a manuscript, should be instructed specifically with respect to 
conflicts of interest. Precisely because they are experts in the field under consideration (i. e. , they 
are peers), reviewers are apt to have conflicts of interest, financial or otherwise. Thus the 
existence of a conflict is not really the issue, but rather whether the conflict is sufficient to limit 
the reviewer's ability to evaluate the manuscript fairly and objectively. Journals should instruct 
their reviewers to disqualify themselves if they feel they cannot render fair and objective 
assessments. If reviewers have any questions in this regard, they should be urged to consult with 
the editor. 
Most journals approach this issue with fairly general and open-ended advice. However, 
JAMA requires reviewers to complete a specific section of the review form disclosing any 
potential conflicts of interest. This assures that the reviewer consider the issue and make a direct 
statement that he or she has or does not have any such conflicts. 
Some reviewers believe that a conflict exists if they have reviewed a manuscript before 
for another journal. If a reviewer still believes the manuscript can be reviewed objectively, many 
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editors prefer to send the manuscript to the same reviewer again. That reviewer is in a good 
position to judge whether the manuscript has been improved. 
Editors 
The journal editor is responsible for establishing and maintaining the highest possible 
standards in the contributions that fill the pages of the journal as well as for maintaining the 
integrity of the journal itself. Editors are primarily responsible for ensuring a fair review process 
of manuscripts submitted to a journal and should give unbiased consideration to all submitted 
manuscripts. Editors should not have personal financial involvement in manuscripts they 
consider for publication. An editor should disqualify him- or herself from any decision-making 
role on a manuscript addressing a subject on which he or she has a potential conflict of interest. 
Some journals stipulate that editors may have no financial interests in any business that might 
influence the publication of a manuscript. Other journals request editors to sign financial 
disclosure forms annually. 
Editors may also disqualify themselves from evaluating submissions by local colleagues 
or friends or submissions that clash with their religious convictions. For example, an editor may 
preclude him or herself from being involved in the review process of a manuscript written by a 
close colleague. In these instances, the editor, who is usually blinded to the reviewers of the 
manuscript, generally asks a guest editor or associate editor to oversee the review process. The 
guest editor makes the final decision on the manuscript. Some editors consider reviewing 
manuscripts submitted by members of the journal's editorial board a conflict and will ask a guest 
editor to oversee those manuscripts. Editors are, after all, human and subject to many of the same 
biases and conflicts as reviewers and authors. 
Recommendations 
The Editorial Policy Committee recommends that: 
~ Journals require authors to explicitly state all sources of funding for research and to 
include this information in the acknowledgement section of the published paper. 
~ Journals require authors to stats other potential conflicts of interest in the cover letter of 
the manuscript submission. 
~ Journals publish financial interests or support with an article. The editor should decide 
ether to include a description with the published article or letter of all financial support 
or any conflicts of interest the editor feels the readers should know. This should be 
published as a footnote on the first page of the manuscript. 
~ Journals should have a policy about how to handle undisclosed conflicts after they are 
identified by a third parly and some explanation to the readers. 
~ Journals should have a policy and plan of action regarding undisclosed financial interests 
that are identified atter publication. Editors may choose to publish a notice of "Failure to 
Disclose Financial lnteresh" 
~ All authors, editors, and reviewers should disclose potential conflicts of interest. Authors 
and reviewers should disclose to the editor; the editor should disclose potential conflicts 
of interest to thc publications committee, or its equivalent. 
In our view, declaring more is better than declaring less. With the input of the authors, 
the editors can choose what information the readers need to know regarding potential conflicts. 
Ask the question: "If these facts were undeclared and emerged later by some other route, 
would they give cause for embarrassment or recrimination?" The readers and the editorial staff 
should be made aware of any conflicts of interest so that they have the necessary information to 
make informed judgments about the potential effects of those conflicts on the manuscript. 
Responsibilities and Rights of Peer Reviewers 
Definition 
Peer reviewers are the linchpin in the process by which research becomes knowledge. 
The process is publication — usually print, but increasingly Internet-based or other electronic 
publication. 
As described by F. Peter Woodford in Scientific Writing for Graduate Students, peer 
reviewers are "responsible scientists anxious only to further science. 
" Accordingly, they 
volunteer to assess the strengths and weaknesses of the work of one or a group of researchers for 
the editors of a publication to which that work has been submitted. The purpose of the peer 
review process is to assure the accuracy and rigor of any work prior to its being widely 
disseminated. 
Peer review is a gift of uncompensated time by people to whom time is a precious 
commodity. It is important, therefore, to define the rights and responsibilities of this group of 
people to whom thc scientific community owes so much. 
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Responsibilities 
Responsibility to the Scientific Community 
Peer reviewers first and foremost must fulfill their responsibility simultaneously to the 
scientific community and to the journal that has requested their assistance. By rigorously 
assessing a given research manuscript within time limits specified by the journal, they meet their 
responsibility to the scientific community in full. 
Responsibility to Authors 
Reviewers who agree to examine thc work of a peer and comment upon its accuracy, its 
clarity, its importance, and its usefulness to the scientific world have a weighty responsibility. 
First and foremost is their obligation to treat the author and the manuscript with respect. When 
reviewers have a bias against either the researchers or the research, they must excuse themselves. 
When reviewers have a conflict of interest with the research or the sponsors of the research, they 
must make it known to the editors or excuse themselves. When reviewers are not truly 
knowledgeable about the area of research in the manuscript they have been asked to review, they 
must decline to review it. 
Second, reviewers must provide an honest assessment of the value of the research. An 
appropriate assessment includes an analysis of the strengths and weaknesses of the study, 
suggestions for avenues to pursue to make the study more complete or relevant, specific 
questions for the authors to address to make their study acceptable and useful to the audience for 
which it is intended. 
Third, reviewers must maintain confidentiality about the manuscripts they review. Using 
the data from such manuscripts before they are published is inappropriate. Sharing the data with 
colleagues is equally inappropriate, as is reproducing the manuscript for any purpose. 
Fourth, reviewers must not use the peer review process as a means to further their own 
research aims, specifically by requiring authors to respond to questions that are of interest to the 
reviewer but are not questions their study was designed to answer. 
Fifth, reviewers should resist the temptation to use their reviews as an opportunity to 
suggest that their own published work be referenced. 
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Responsibility to Journals 
Reviewers' responsibilities to journals fall into several categories: quality and timing of 
reviews and avoidance of conflicts of interest. 
When reviewers receive invitations to review manuscripts and it is unlikely that the 
reviews can be finished within the time frame specified by the journal, they should decline the 
opportunity and explain the reason. This accomplishes two objectives: keeping the manuscript 
on an appropriate schedule and informing the editorial oflice that the reviewers should not be 
sent additional manuscripts in the near future. 
Once reviewers agree to review manuscripts, it is incumbent upon them to return their 
reviews to the editorial office within the specified time frame. If it becomes impossible to 
complete the review on time, reviewers should so inform the editorial office and ask for 
guidance about whether to return the manuscripts unreviewed or take the additional time needed 
to finish them. 
When reviewers receive invitations to review manuscripts with which they have a clear 
conflict of interest, it is their responsibility to turn down the invitation or divulge the conflict of 
interest, Conflicts of interest can be of several sorts, the most common being a relationship 
between the reviewers with either the company that sponsored the research or with a company 
that competes with the sponsor of the research to be reviewed. It is fairest for reviewers with 
such conflicts of interest to decline the reviews. 
On the other hand, when reviewers receive invitations to review manuscripts that 
advocate positions against which they have a bias, the situation is more complex and the decision 
more personal. Should, for example, clinicians who advocate aggressive treatment for patients 
with a specific disease review manuscripts that advocate a nonaggressive approach to therapy for 
patients with that disease? In general, such reviewers should make that determination personally. 
The fact that a journal editorial office requested their input into such manuscripts suggests that 
the editor is looking for balanced reviews and has likely chosen another reviewer or reviewers 
who support thc nonaggressive approach to such patients to provide perspective. With that in 
mind, reviewers should respond positively if they believe they can review within the specified 
time frame. 
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Rights 
Reviewers have the right to expect to be informed of the outcome of the review process 
for the manuscripts they refereed for journals. Whether that information is forthcoming while a 
manuscript remains active — as, for instance, when one is returned to its authors for a revision- 
or whether it is imparted only once a definitive decision is reached is up to the journal. 
Regardless of the timing of notification, however, reviewers should ultimately be informed. As 
an educational service and in the hope of helping the reviewers with future reviews, it is a nicety 
to send each reviewer the comments of the other reviewer(s) for their edification, 
Reviewers should also expect to be thanked for the time they take to review manuscripts. 
A journal's thank you to its reviewers can take several forms, any one of which is acceptable. 
Some journals give reviewers who are not subscribers a brief subscription to the journal. Many 
journals publish a list of their reviewers for a given year in the journal early in the subsequent 
year. Some journals arrange a social or educational event, generally at a large specialty meeting, 
to which their reviewers are invited. 
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